pharmaobservatory 0.1.0 → 0.1.2
This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
- checksums.yaml +4 -4
- data/README.md +418 -182
- data/docs/BiomarkersApi.md +1596 -0
- data/docs/BiomarkersAssayProviderLedger200Response.md +40 -0
- data/docs/BiomarkersAssayProviderLedger200ResponseAttributionInner.md +22 -0
- data/docs/BiomarkersAssayProviderLedger200ResponsePagination.md +28 -0
- data/docs/BiomarkersAssayProviderLedger200ResponseRowsInner.md +42 -0
- data/docs/BiomarkersCgi200Response.md +40 -0
- data/docs/BiomarkersCgi200ResponseAttributionInner.md +22 -0
- data/docs/BiomarkersCgi200ResponseRowsInner.md +34 -0
- data/docs/BiomarkersCoverageByTraversal200Response.md +38 -0
- data/docs/BiomarkersCoverageByTraversal200ResponseRowsInner.md +28 -0
- data/docs/BiomarkersEvidenceOverTime200Response.md +40 -0
- data/docs/BiomarkersEvidenceOverTime200ResponseContext.md +18 -0
- data/docs/BiomarkersEvidenceOverTime200ResponseRowsInner.md +32 -0
- data/docs/BiomarkersFdaBqp200Response.md +40 -0
- data/docs/BiomarkersFdaBqp200ResponseRowsInner.md +38 -0
- data/docs/BiomarkersFdaCdx200Response.md +40 -0
- data/docs/BiomarkersFdaCdx200ResponseRowsInner.md +38 -0
- data/docs/BiomarkersGet200Response.md +32 -0
- data/docs/BiomarkersGet200ResponseIdentity.md +20 -0
- data/docs/BiomarkersGet200ResponseIdentityRowsInner.md +22 -0
- data/docs/BiomarkersGet200ResponseIdentityRowsInnerValue.md +49 -0
- data/docs/BiomarkersGet200ResponseResolutionConfidence.md +20 -0
- data/docs/BiomarkersGet200ResponseSectionsInner.md +34 -0
- data/docs/BiomarkersHubTierTables200Response.md +38 -0
- data/docs/BiomarkersHubTierTables200ResponseRowsInner.md +28 -0
- data/docs/BiomarkersIdentity200Response.md +40 -0
- data/docs/BiomarkersList200Response.md +44 -0
- data/docs/BiomarkersList200ResponseAttributionInner.md +22 -0
- data/docs/BiomarkersList200ResponseBuildState.md +22 -0
- data/docs/BiomarkersList200ResponseColumnsInner.md +22 -0
- data/docs/BiomarkersList200ResponseFacetsInner.md +22 -0
- data/docs/BiomarkersList200ResponseFacetsInnerOptionsInner.md +22 -0
- data/docs/BiomarkersList200ResponsePagination.md +28 -0
- data/docs/BiomarkersList200ResponseQuery.md +28 -0
- data/docs/BiomarkersList200ResponseQueryFilters.md +20 -0
- data/docs/BiomarkersList200ResponseRowsInner.md +56 -0
- data/docs/BiomarkersList200ResponseShape.md +18 -0
- data/docs/BiomarkersLiterature200Response.md +42 -0
- data/docs/BiomarkersLiterature200ResponseContext.md +20 -0
- data/docs/BiomarkersLiterature200ResponseRowsInner.md +28 -0
- data/docs/BiomarkersOtAssociation200Response.md +40 -0
- data/docs/BiomarkersOtAssociation200ResponseRowsInner.md +28 -0
- data/docs/BiomarkersPopulationAlleleFrequency200Response.md +38 -0
- data/docs/BiomarkersPopulationAlleleFrequency200ResponseAttributionInner.md +24 -0
- data/docs/BiomarkersPopulationAlleleFrequency200ResponseRowsInner.md +38 -0
- data/docs/BiomarkersPublishingOrg200Response.md +42 -0
- data/docs/BiomarkersPublishingOrg200ResponseContext.md +24 -0
- data/docs/BiomarkersPublishingOrg200ResponseRowsInner.md +34 -0
- data/docs/BiomarkersRelatedBiomarkers200Response.md +38 -0
- data/docs/BiomarkersRelatedBiomarkers200ResponseRowsInner.md +22 -0
- data/docs/BiomarkersRelatedConditions200Response.md +38 -0
- data/docs/BiomarkersRelatedOrganizations200Response.md +38 -0
- data/docs/BiomarkersRelations200Response.md +44 -0
- data/docs/BiomarkersRelations200ResponseContext.md +20 -0
- data/docs/BiomarkersRelations200ResponseContextFilters.md +24 -0
- data/docs/BiomarkersRelations200ResponseQuery.md +18 -0
- data/docs/BiomarkersRelations200ResponseRowsInner.md +32 -0
- data/docs/BiomarkersRelations400Response.md +22 -0
- data/docs/BiomarkersSampleScreening200Response.md +42 -0
- data/docs/BiomarkersSampleScreening200ResponseContext.md +26 -0
- data/docs/BiomarkersSampleScreening200ResponseContextCoverageCounts.md +20 -0
- data/docs/BiomarkersSampleScreening200ResponseRowsInner.md +38 -0
- data/docs/BiomarkersSampleScreening200ResponseRowsInnerReferenceScreens.md +22 -0
- data/docs/BiomarkersTrialMention200Response.md +40 -0
- data/docs/BiomarkersTrialMention200ResponseRowsInner.md +26 -0
- data/docs/BiomarkersVariantMentions200Response.md +40 -0
- data/docs/BiomarkersVariantMentions200ResponseRowsInner.md +28 -0
- data/docs/BiomarkersVendorSourcing200Response.md +42 -0
- data/docs/BiomarkersVendorSourcing200ResponseQuery.md +18 -0
- data/docs/BiomarkersVendorSourcing200ResponseRowsInner.md +46 -0
- data/docs/BiomarkersWhereItAppears200Response.md +38 -0
- data/docs/BiomarkersWhereItAppears200ResponseRowsInner.md +22 -0
- data/docs/CellLinesApi.md +357 -0
- data/docs/CellLinesGet200Response.md +32 -0
- data/docs/CellLinesGet200ResponseIdentity.md +20 -0
- data/docs/CellLinesGet200ResponseIdentityRowsInner.md +22 -0
- data/docs/CellLinesIdentity200Response.md +40 -0
- data/docs/CellLinesList200Response.md +44 -0
- data/docs/CellLinesList200ResponseAttributionInner.md +26 -0
- data/docs/CellLinesList200ResponseQuery.md +18 -0
- data/docs/CellLinesList200ResponseQueryFilters.md +18 -0
- data/docs/CellLinesList200ResponseRowsInner.md +38 -0
- data/docs/CellLinesSafetyResolution200Response.md +38 -0
- data/docs/CellLinesSafetyResolution200ResponseRowsInner.md +22 -0
- data/docs/CellLinesSafetyResolution200ResponseRowsInnerValue.md +49 -0
- data/docs/CellLinesStatusCounts200Response.md +38 -0
- data/docs/CellLinesStatusCounts200ResponseRowsInner.md +22 -0
- data/docs/NotEntitledError.md +22 -2
- data/docs/OrgsActivePrograms200Response.md +40 -0
- data/docs/OrgsActivitySummary200Response.md +38 -0
- data/docs/OrgsActivitySummary200ResponseRowsInner.md +20 -0
- data/docs/OrgsApi.md +5982 -0
- data/docs/OrgsApprovedAssets200Response.md +42 -0
- data/docs/OrgsApprovedAssets200ResponseContext.md +20 -0
- data/docs/OrgsApprovedAssets200ResponseRowsInner.md +24 -0
- data/docs/OrgsBenzingaCatalysts200Response.md +40 -0
- data/docs/OrgsBenzingaCatalysts200ResponseAttributionInner.md +22 -0
- data/docs/OrgsBenzingaCatalysts200ResponseRestriction.md +22 -0
- data/docs/OrgsBiomarkerCapability200Response.md +40 -0
- data/docs/OrgsClia200Response.md +40 -0
- data/docs/OrgsClimate200Response.md +40 -0
- data/docs/OrgsClimate200ResponseRowsInner.md +56 -0
- data/docs/OrgsCollaborators200Response.md +38 -0
- data/docs/OrgsCollaborators200ResponseRowsInner.md +24 -0
- data/docs/OrgsCompany200Response.md +38 -0
- data/docs/OrgsCompany200ResponseRowsInner.md +86 -0
- data/docs/OrgsCompetitors200Response.md +38 -0
- data/docs/OrgsCompetitors200ResponseRowsInner.md +58 -0
- data/docs/OrgsCoverage200Response.md +38 -0
- data/docs/OrgsCoverage200ResponseRowsInner.md +22 -0
- data/docs/OrgsCoverage200ResponseRowsInnerValue.md +49 -0
- data/docs/OrgsCurrentOwnership200Response.md +42 -0
- data/docs/OrgsCurrentOwnership200ResponseAttributionInner.md +24 -0
- data/docs/OrgsCurrentOwnership200ResponseContext.md +22 -0
- data/docs/OrgsCurrentOwnership200ResponseContextTotals.md +20 -0
- data/docs/OrgsCurrentOwnership200ResponseRowsInner.md +72 -0
- data/docs/OrgsDeclarations200Response.md +38 -0
- data/docs/OrgsDeclarations200ResponseRowsInner.md +40 -0
- data/docs/OrgsDelivery200Response.md +38 -0
- data/docs/OrgsDelivery200ResponseRowsInner.md +32 -0
- data/docs/OrgsDescription200Response.md +38 -0
- data/docs/OrgsDescription200ResponseRowsInner.md +20 -0
- data/docs/OrgsDiseaseAreas200Response.md +42 -0
- data/docs/OrgsDiseaseAreas200ResponseRowsInner.md +22 -0
- data/docs/OrgsDiversity200Response.md +40 -0
- data/docs/OrgsDiversity200ResponseRowsInner.md +50 -0
- data/docs/OrgsEsgTrend200Response.md +40 -0
- data/docs/OrgsEsgTrend200ResponseAttributionInner.md +22 -0
- data/docs/OrgsEsgTrend200ResponseContext.md +18 -0
- data/docs/OrgsEsgTrend200ResponseRowsInner.md +32 -0
- data/docs/OrgsFinancialLineItems200Response.md +40 -0
- data/docs/OrgsFinancialLineItems200ResponseContext.md +22 -0
- data/docs/OrgsFinancialLineItems200ResponseContextGroupsInner.md +22 -0
- data/docs/OrgsFinancialLineItems200ResponseRowsInner.md +28 -0
- data/docs/OrgsFinancialOverview200Response.md +40 -0
- data/docs/OrgsFinancialOverview200ResponseContext.md +20 -0
- data/docs/OrgsFinancialOverview200ResponseRowsInner.md +22 -0
- data/docs/OrgsFinancialOverview200ResponseRowsInnerValue.md +53 -0
- data/docs/OrgsFinancials200Response.md +42 -0
- data/docs/OrgsFinancials200ResponseRowsInner.md +26 -0
- data/docs/OrgsFunding200Response.md +42 -0
- data/docs/OrgsFunding200ResponseContext.md +32 -0
- data/docs/OrgsFunding200ResponseContextSummary.md +28 -0
- data/docs/OrgsFunding200ResponseRowsInner.md +38 -0
- data/docs/OrgsGet200Response.md +32 -0
- data/docs/OrgsGet200ResponseIdentity.md +20 -0
- data/docs/OrgsGet200ResponseIdentityRowsInner.md +22 -0
- data/docs/OrgsGet200ResponseIdentityRowsInnerValue.md +55 -0
- data/docs/OrgsGet200ResponseSectionsInner.md +34 -0
- data/docs/OrgsGroupSections200Response.md +40 -0
- data/docs/OrgsGroupSections200ResponseContext.md +28 -0
- data/docs/OrgsGroupSections200ResponseRowsInner.md +34 -0
- data/docs/OrgsGroupStructure200Response.md +40 -0
- data/docs/OrgsGroupStructure200ResponseContext.md +22 -0
- data/docs/OrgsGroupStructure200ResponseRowsInner.md +36 -0
- data/docs/OrgsGxpSites200Response.md +42 -0
- data/docs/OrgsGxpSites200ResponseContext.md +24 -0
- data/docs/OrgsGxpSites200ResponseContextGroupCompaniesInner.md +22 -0
- data/docs/OrgsGxpSites200ResponseRowsInner.md +50 -0
- data/docs/OrgsGxpSitesMap200Response.md +40 -0
- data/docs/OrgsIdentity200Response.md +40 -0
- data/docs/OrgsImportRefusals200Response.md +38 -0
- data/docs/OrgsInstitutional13f200Response.md +42 -0
- data/docs/OrgsInstitutional13f200ResponseContext.md +22 -0
- data/docs/OrgsInstitutional13f200ResponseRowsInner.md +62 -0
- data/docs/OrgsJournals200Response.md +42 -0
- data/docs/OrgsList200Response.md +42 -0
- data/docs/OrgsList200ResponsePagination.md +28 -0
- data/docs/OrgsList200ResponseQuery.md +26 -0
- data/docs/OrgsList200ResponseRowsInner.md +44 -0
- data/docs/OrgsMemberChildren200Response.md +38 -0
- data/docs/OrgsMemberIdentity200Response.md +42 -0
- data/docs/OrgsMemberIdentity200ResponseContext.md +28 -0
- data/docs/OrgsMemberIdentity200ResponseContextIdentifiersInner.md +22 -0
- data/docs/OrgsMemberIdentity200ResponseContextParent.md +22 -0
- data/docs/OrgsMemberIdentity200ResponseRowsInner.md +26 -0
- data/docs/OrgsMemberRecords200Response.md +40 -0
- data/docs/OrgsMemberRecords200ResponseContext.md +18 -0
- data/docs/OrgsMemberRecords200ResponseRowsInner.md +22 -0
- data/docs/OrgsMembers200Response.md +42 -0
- data/docs/OrgsMembers200ResponseRowsInner.md +24 -0
- data/docs/OrgsOrgAssets200Response.md +40 -0
- data/docs/OrgsOrgAssets200ResponseRowsInner.md +32 -0
- data/docs/OrgsOrgCustomer200Response.md +38 -0
- data/docs/OrgsOrgCustomer200ResponseRowsInner.md +18 -0
- data/docs/OrgsOrgGleif200Response.md +38 -0
- data/docs/OrgsOrgGleif200ResponseRowsInner.md +24 -0
- data/docs/OrgsOrgHosted200Response.md +38 -0
- data/docs/OrgsOrgHosted200ResponseRowsInner.md +22 -0
- data/docs/OrgsOrgOwnedDrugs200Response.md +40 -0
- data/docs/OrgsOrgOwnedDrugs200ResponseRowsInner.md +30 -0
- data/docs/OrgsOrgOwnership200Response.md +40 -0
- data/docs/OrgsOrgOwnership200ResponseContext.md +26 -0
- data/docs/OrgsOrgOwnership200ResponseContextTruncated.md +20 -0
- data/docs/OrgsOrgPatentMentions200Response.md +40 -0
- data/docs/OrgsOrgPatentMentions200ResponseAttributionInner.md +24 -0
- data/docs/OrgsOrgPatentMentions200ResponseRowsInner.md +28 -0
- data/docs/OrgsOrgPeople200Response.md +42 -0
- data/docs/OrgsOrgPeople200ResponseContext.md +18 -0
- data/docs/OrgsOrgPeople200ResponseRowsInner.md +26 -0
- data/docs/OrgsOrgPipeline200Response.md +42 -0
- data/docs/OrgsOrgPipeline200ResponseContext.md +20 -0
- data/docs/OrgsOrgPipeline200ResponseContextCounts.md +22 -0
- data/docs/OrgsOrgPipeline200ResponseRowsInner.md +28 -0
- data/docs/OrgsOrgPrograms200Response.md +44 -0
- data/docs/OrgsOrgPrograms200ResponseContext.md +20 -0
- data/docs/OrgsOrgPrograms200ResponseRowsInner.md +36 -0
- data/docs/OrgsOrgPublications200Response.md +40 -0
- data/docs/OrgsOrgPublications200ResponseRowsInner.md +22 -0
- data/docs/OrgsOrgRecruitment200Response.md +40 -0
- data/docs/OrgsOrgRecruitment200ResponseContext.md +58 -0
- data/docs/OrgsOrgRecruitment200ResponseContextPredicted.md +24 -0
- data/docs/OrgsOrgRecruitment200ResponseContextRealized.md +22 -0
- data/docs/OrgsOrgRecruitment200ResponseContextStatuses.md +32 -0
- data/docs/OrgsOrgRelationships200Response.md +42 -0
- data/docs/OrgsOrgRelationships200ResponseQuery.md +20 -0
- data/docs/OrgsOrgSupplier200Response.md +38 -0
- data/docs/OrgsOrgSupplier200ResponseRowsInner.md +26 -0
- data/docs/OrgsOrgTargets200Response.md +40 -0
- data/docs/OrgsOrgTargets200ResponseRowsInner.md +28 -0
- data/docs/OrgsOrgTypeTally200Response.md +40 -0
- data/docs/OrgsOrgTypeTally200ResponseContext.md +18 -0
- data/docs/OrgsOrgTypeTally200ResponseRowsInner.md +20 -0
- data/docs/OrgsOrgUsPatents200Response.md +42 -0
- data/docs/OrgsOrgUsPatents200ResponseContext.md +26 -0
- data/docs/OrgsOrgUsPatents200ResponseRowsInner.md +24 -0
- data/docs/OrgsOverviewDigest200Response.md +38 -0
- data/docs/OrgsOverviewDigest200ResponseRowsInner.md +24 -0
- data/docs/OrgsOwnershipCoverage200Response.md +38 -0
- data/docs/OrgsOwnershipCoverage200ResponseRowsInner.md +38 -0
- data/docs/OrgsOwnershipHistory200Response.md +42 -0
- data/docs/OrgsOwnershipHistory200ResponseContext.md +20 -0
- data/docs/OrgsOwnershipHistory200ResponseRowsInner.md +60 -0
- data/docs/OrgsOwnershipPercentages200Response.md +40 -0
- data/docs/OrgsOwnershipPercentages200ResponseContext.md +24 -0
- data/docs/OrgsOwnershipPercentages200ResponseContextInsider.md +40 -0
- data/docs/OrgsOwnershipPercentages200ResponseContextInstitutional.md +42 -0
- data/docs/OrgsOwnershipPercentages200ResponseContextSharesOutstanding.md +28 -0
- data/docs/OrgsOwnershipPercentages200ResponseRowsInner.md +30 -0
- data/docs/OrgsOwnershipPercentages200ResponseRowsInnerAsOf.md +49 -0
- data/docs/OrgsPatentCliff200Response.md +40 -0
- data/docs/OrgsPatentCliff200ResponseContext.md +18 -0
- data/docs/OrgsPatentCliff200ResponseRowsInner.md +36 -0
- data/docs/OrgsPatentVsTrial200Response.md +40 -0
- data/docs/OrgsPatentVsTrial200ResponseContext.md +24 -0
- data/docs/OrgsPatentVsTrial200ResponseContextPortfolio.md +24 -0
- data/docs/OrgsPatentVsTrial200ResponseRowsInner.md +22 -0
- data/docs/OrgsPatents200Response.md +40 -0
- data/docs/OrgsPatents200ResponseContext.md +22 -0
- data/docs/OrgsPatents200ResponseRowsInner.md +22 -0
- data/docs/OrgsPdufaReconciliation200Response.md +42 -0
- data/docs/OrgsPdufaReconciliation200ResponseContext.md +24 -0
- data/docs/OrgsPdufaReconciliation200ResponseContextStatusCounts.md +22 -0
- data/docs/OrgsPdufaReconciliation200ResponseRowsInner.md +32 -0
- data/docs/OrgsPeers200Response.md +38 -0
- data/docs/OrgsPeers200ResponseRowsInner.md +44 -0
- data/docs/OrgsPhaseStatus200Response.md +40 -0
- data/docs/OrgsPhaseStatus200ResponseContext.md +18 -0
- data/docs/OrgsPhaseStatus200ResponseRowsInner.md +26 -0
- data/docs/OrgsPublishingBiomarkers200Response.md +42 -0
- data/docs/OrgsPublishingBiomarkers200ResponseContext.md +22 -0
- data/docs/OrgsPublishingBiomarkers200ResponseContextCoverage.md +24 -0
- data/docs/OrgsRareActivity200Response.md +42 -0
- data/docs/OrgsRareActivity200ResponseContext.md +18 -0
- data/docs/OrgsRareActivity200ResponseRowsInner.md +40 -0
- data/docs/OrgsRegistryShell200Response.md +38 -0
- data/docs/OrgsRegistryShell200ResponseRowsInner.md +20 -0
- data/docs/OrgsRelatedConditions200Response.md +38 -0
- data/docs/OrgsRelatedConditions200ResponseRowsInner.md +20 -0
- data/docs/OrgsRelatedUnfolded200Response.md +42 -0
- data/docs/OrgsRelatedUnfolded200ResponseRowsInner.md +22 -0
- data/docs/OrgsRevenueByDrug200Response.md +40 -0
- data/docs/OrgsRevenueByDrug200ResponseContext.md +20 -0
- data/docs/OrgsRevenueByDrug200ResponseRowsInner.md +24 -0
- data/docs/OrgsRevenueGeography200Response.md +40 -0
- data/docs/OrgsRevenueGeography200ResponseContext.md +18 -0
- data/docs/OrgsRevenueGeography200ResponseRowsInner.md +26 -0
- data/docs/OrgsSameNameSecFiler200Response.md +38 -0
- data/docs/OrgsSameNameSecFiler200ResponseRowsInner.md +34 -0
- data/docs/OrgsSbtiCrosscheck200Response.md +40 -0
- data/docs/OrgsSbtiCrosscheck200ResponseRowsInner.md +20 -0
- data/docs/OrgsScientistCom200Response.md +40 -0
- data/docs/OrgsScientistCom200ResponseContext.md +18 -0
- data/docs/OrgsScientistCom200ResponseRowsInner.md +26 -0
- data/docs/OrgsSecFilerShell200Response.md +38 -0
- data/docs/OrgsSecFilerShell200ResponseRowsInner.md +22 -0
- data/docs/OrgsSecFilerShell200ResponseRowsInnerValue.md +55 -0
- data/docs/OrgsSecFilerShell200ResponseRowsInnerValueOneOf.md +34 -0
- data/docs/OrgsSecPdufa200Response.md +38 -0
- data/docs/OrgsSecPdufa200ResponseRowsInner.md +36 -0
- data/docs/OrgsSupplierLinks200Response.md +38 -0
- data/docs/OrgsTimeline200Response.md +42 -0
- data/docs/OrgsTimeline200ResponseRowsInner.md +34 -0
- data/docs/OrgsTopConditions200Response.md +38 -0
- data/docs/OrgsTopConditions200ResponseRowsInner.md +22 -0
- data/docs/OrgsTopDrugs200Response.md +38 -0
- data/docs/OrgsTopDrugs200ResponseRowsInner.md +20 -0
- data/docs/OrgsTrialsPerYear200Response.md +40 -0
- data/docs/OrgsUnmatchedRevenue200Response.md +40 -0
- data/docs/OrgsUnmatchedRevenue200ResponseRowsInner.md +22 -0
- data/docs/OrgsUnmatchedRevenue200ResponseRowsInnerValue.md +49 -0
- data/lib/pharmaobservatory/api/api_v1_base_api.rb +1 -1
- data/lib/pharmaobservatory/api/biomarkers_api.rb +1449 -0
- data/lib/pharmaobservatory/api/cell_lines_api.rb +330 -0
- data/lib/pharmaobservatory/api/orgs_api.rb +5372 -0
- data/lib/pharmaobservatory/api_client.rb +1 -1
- data/lib/pharmaobservatory/api_error.rb +1 -1
- data/lib/pharmaobservatory/configuration.rb +2 -2
- data/lib/pharmaobservatory/models/api_v1_whoami_get200_response.rb +1 -1
- data/lib/pharmaobservatory/models/auth_error.rb +1 -1
- data/lib/pharmaobservatory/models/biomarkers_assay_provider_ledger200_response.rb +515 -0
- data/lib/pharmaobservatory/models/biomarkers_assay_provider_ledger200_response_attribution_inner.rb +275 -0
- data/lib/pharmaobservatory/models/biomarkers_assay_provider_ledger200_response_pagination.rb +339 -0
- data/lib/pharmaobservatory/models/biomarkers_assay_provider_ledger200_response_rows_inner.rb +479 -0
- data/lib/pharmaobservatory/models/biomarkers_cgi200_response.rb +515 -0
- data/lib/pharmaobservatory/models/biomarkers_cgi200_response_attribution_inner.rb +289 -0
- data/lib/pharmaobservatory/models/biomarkers_cgi200_response_rows_inner.rb +431 -0
- data/lib/pharmaobservatory/models/biomarkers_coverage_by_traversal200_response.rb +489 -0
- data/lib/pharmaobservatory/models/biomarkers_coverage_by_traversal200_response_rows_inner.rb +367 -0
- data/lib/pharmaobservatory/models/biomarkers_evidence_over_time200_response.rb +498 -0
- data/lib/pharmaobservatory/models/biomarkers_evidence_over_time200_response_context.rb +239 -0
- data/lib/pharmaobservatory/models/biomarkers_evidence_over_time200_response_rows_inner.rb +349 -0
- data/lib/pharmaobservatory/models/biomarkers_fda_bqp200_response.rb +515 -0
- data/lib/pharmaobservatory/models/biomarkers_fda_bqp200_response_rows_inner.rb +469 -0
- data/lib/pharmaobservatory/models/biomarkers_fda_cdx200_response.rb +515 -0
- data/lib/pharmaobservatory/models/biomarkers_fda_cdx200_response_rows_inner.rb +469 -0
- data/lib/pharmaobservatory/models/biomarkers_get200_response.rb +423 -0
- data/lib/pharmaobservatory/models/biomarkers_get200_response_identity.rb +267 -0
- data/lib/pharmaobservatory/models/biomarkers_get200_response_identity_rows_inner.rb +275 -0
- data/lib/pharmaobservatory/models/biomarkers_get200_response_identity_rows_inner_value.rb +105 -0
- data/lib/pharmaobservatory/models/biomarkers_get200_response_resolution_confidence.rb +263 -0
- data/lib/pharmaobservatory/models/biomarkers_get200_response_sections_inner.rb +417 -0
- data/lib/pharmaobservatory/models/biomarkers_hub_tier_tables200_response.rb +475 -0
- data/lib/pharmaobservatory/models/biomarkers_hub_tier_tables200_response_rows_inner.rb +367 -0
- data/lib/pharmaobservatory/models/biomarkers_identity200_response.rb +515 -0
- data/lib/pharmaobservatory/models/biomarkers_list200_response.rb +538 -0
- data/lib/pharmaobservatory/models/biomarkers_list200_response_attribution_inner.rb +275 -0
- data/lib/pharmaobservatory/models/biomarkers_list200_response_build_state.rb +275 -0
- data/lib/pharmaobservatory/models/biomarkers_list200_response_columns_inner.rb +289 -0
- data/lib/pharmaobservatory/models/biomarkers_list200_response_facets_inner.rb +291 -0
- data/lib/pharmaobservatory/models/biomarkers_list200_response_facets_inner_options_inner.rb +289 -0
- data/lib/pharmaobservatory/models/biomarkers_list200_response_pagination.rb +339 -0
- data/lib/pharmaobservatory/models/biomarkers_list200_response_query.rb +353 -0
- data/lib/pharmaobservatory/models/biomarkers_list200_response_query_filters.rb +233 -0
- data/lib/pharmaobservatory/models/biomarkers_list200_response_rows_inner.rb +633 -0
- data/lib/pharmaobservatory/models/biomarkers_list200_response_shape.rb +237 -0
- data/lib/pharmaobservatory/models/biomarkers_literature200_response.rb +524 -0
- data/lib/pharmaobservatory/models/biomarkers_literature200_response_context.rb +263 -0
- data/lib/pharmaobservatory/models/biomarkers_literature200_response_rows_inner.rb +367 -0
- data/lib/pharmaobservatory/models/biomarkers_ot_association200_response.rb +515 -0
- data/lib/pharmaobservatory/models/biomarkers_ot_association200_response_rows_inner.rb +367 -0
- data/lib/pharmaobservatory/models/biomarkers_population_allele_frequency200_response.rb +489 -0
- data/lib/pharmaobservatory/models/biomarkers_population_allele_frequency200_response_attribution_inner.rb +315 -0
- data/lib/pharmaobservatory/models/biomarkers_population_allele_frequency200_response_rows_inner.rb +385 -0
- data/lib/pharmaobservatory/models/biomarkers_publishing_org200_response.rb +524 -0
- data/lib/pharmaobservatory/models/biomarkers_publishing_org200_response_context.rb +315 -0
- data/lib/pharmaobservatory/models/biomarkers_publishing_org200_response_rows_inner.rb +419 -0
- data/lib/pharmaobservatory/models/biomarkers_related_biomarkers200_response.rb +489 -0
- data/lib/pharmaobservatory/models/biomarkers_related_biomarkers200_response_rows_inner.rb +289 -0
- data/lib/pharmaobservatory/models/biomarkers_related_conditions200_response.rb +489 -0
- data/lib/pharmaobservatory/models/biomarkers_related_organizations200_response.rb +489 -0
- data/lib/pharmaobservatory/models/biomarkers_relations200_response.rb +550 -0
- data/lib/pharmaobservatory/models/biomarkers_relations200_response_context.rb +263 -0
- data/lib/pharmaobservatory/models/biomarkers_relations200_response_context_filters.rb +315 -0
- data/lib/pharmaobservatory/models/biomarkers_relations200_response_query.rb +237 -0
- data/lib/pharmaobservatory/models/biomarkers_relations200_response_rows_inner.rb +419 -0
- data/lib/pharmaobservatory/models/biomarkers_relations400_response.rb +291 -0
- data/lib/pharmaobservatory/models/biomarkers_sample_screening200_response.rb +524 -0
- data/lib/pharmaobservatory/models/biomarkers_sample_screening200_response_context.rb +333 -0
- data/lib/pharmaobservatory/models/biomarkers_sample_screening200_response_context_coverage_counts.rb +263 -0
- data/lib/pharmaobservatory/models/biomarkers_sample_screening200_response_rows_inner.rb +484 -0
- data/lib/pharmaobservatory/models/biomarkers_sample_screening200_response_rows_inner_reference_screens.rb +289 -0
- data/lib/pharmaobservatory/models/biomarkers_trial_mention200_response.rb +515 -0
- data/lib/pharmaobservatory/models/biomarkers_trial_mention200_response_rows_inner.rb +313 -0
- data/lib/pharmaobservatory/models/biomarkers_variant_mentions200_response.rb +515 -0
- data/lib/pharmaobservatory/models/biomarkers_variant_mentions200_response_rows_inner.rb +369 -0
- data/lib/pharmaobservatory/models/biomarkers_vendor_sourcing200_response.rb +541 -0
- data/lib/pharmaobservatory/models/biomarkers_vendor_sourcing200_response_query.rb +237 -0
- data/lib/pharmaobservatory/models/biomarkers_vendor_sourcing200_response_rows_inner.rb +587 -0
- data/lib/pharmaobservatory/models/biomarkers_where_it_appears200_response.rb +489 -0
- data/lib/pharmaobservatory/models/biomarkers_where_it_appears200_response_rows_inner.rb +275 -0
- data/lib/pharmaobservatory/models/cell_lines_get200_response.rb +423 -0
- data/lib/pharmaobservatory/models/cell_lines_get200_response_identity.rb +267 -0
- data/lib/pharmaobservatory/models/cell_lines_get200_response_identity_rows_inner.rb +289 -0
- data/lib/pharmaobservatory/models/cell_lines_identity200_response.rb +515 -0
- data/lib/pharmaobservatory/models/cell_lines_list200_response.rb +538 -0
- data/lib/pharmaobservatory/models/cell_lines_list200_response_attribution_inner.rb +341 -0
- data/lib/pharmaobservatory/models/cell_lines_list200_response_query.rb +237 -0
- data/lib/pharmaobservatory/models/cell_lines_list200_response_query_filters.rb +222 -0
- data/lib/pharmaobservatory/models/cell_lines_list200_response_rows_inner.rb +441 -0
- data/lib/pharmaobservatory/models/cell_lines_safety_resolution200_response.rb +489 -0
- data/lib/pharmaobservatory/models/cell_lines_safety_resolution200_response_rows_inner.rb +289 -0
- data/lib/pharmaobservatory/models/cell_lines_safety_resolution200_response_rows_inner_value.rb +105 -0
- data/lib/pharmaobservatory/models/cell_lines_status_counts200_response.rb +475 -0
- data/lib/pharmaobservatory/models/cell_lines_status_counts200_response_rows_inner.rb +289 -0
- data/lib/pharmaobservatory/models/not_entitled_error.rb +101 -27
- data/lib/pharmaobservatory/models/orgs_active_programs200_response.rb +515 -0
- data/lib/pharmaobservatory/models/orgs_activity_summary200_response.rb +503 -0
- data/lib/pharmaobservatory/models/orgs_activity_summary200_response_rows_inner.rb +263 -0
- data/lib/pharmaobservatory/models/orgs_approved_assets200_response.rb +541 -0
- data/lib/pharmaobservatory/models/orgs_approved_assets200_response_context.rb +263 -0
- data/lib/pharmaobservatory/models/orgs_approved_assets200_response_rows_inner.rb +315 -0
- data/lib/pharmaobservatory/models/orgs_benzinga_catalysts200_response.rb +529 -0
- data/lib/pharmaobservatory/models/orgs_benzinga_catalysts200_response_attribution_inner.rb +289 -0
- data/lib/pharmaobservatory/models/orgs_benzinga_catalysts200_response_restriction.rb +289 -0
- data/lib/pharmaobservatory/models/orgs_biomarker_capability200_response.rb +515 -0
- data/lib/pharmaobservatory/models/orgs_clia200_response.rb +515 -0
- data/lib/pharmaobservatory/models/orgs_climate200_response.rb +515 -0
- data/lib/pharmaobservatory/models/orgs_climate200_response_rows_inner.rb +442 -0
- data/lib/pharmaobservatory/models/orgs_collaborators200_response.rb +489 -0
- data/lib/pharmaobservatory/models/orgs_collaborators200_response_rows_inner.rb +315 -0
- data/lib/pharmaobservatory/models/orgs_company200_response.rb +489 -0
- data/lib/pharmaobservatory/models/orgs_company200_response_rows_inner.rb +1023 -0
- data/lib/pharmaobservatory/models/orgs_competitors200_response.rb +489 -0
- data/lib/pharmaobservatory/models/orgs_competitors200_response_rows_inner.rb +763 -0
- data/lib/pharmaobservatory/models/orgs_coverage200_response.rb +489 -0
- data/lib/pharmaobservatory/models/orgs_coverage200_response_rows_inner.rb +275 -0
- data/lib/pharmaobservatory/models/orgs_coverage200_response_rows_inner_value.rb +105 -0
- data/lib/pharmaobservatory/models/orgs_current_ownership200_response.rb +555 -0
- data/lib/pharmaobservatory/models/orgs_current_ownership200_response_attribution_inner.rb +301 -0
- data/lib/pharmaobservatory/models/orgs_current_ownership200_response_context.rb +272 -0
- data/lib/pharmaobservatory/models/orgs_current_ownership200_response_context_totals.rb +263 -0
- data/lib/pharmaobservatory/models/orgs_current_ownership200_response_rows_inner.rb +849 -0
- data/lib/pharmaobservatory/models/orgs_declarations200_response.rb +489 -0
- data/lib/pharmaobservatory/models/orgs_declarations200_response_rows_inner.rb +503 -0
- data/lib/pharmaobservatory/models/orgs_delivery200_response.rb +503 -0
- data/lib/pharmaobservatory/models/orgs_delivery200_response_rows_inner.rb +391 -0
- data/lib/pharmaobservatory/models/orgs_description200_response.rb +489 -0
- data/lib/pharmaobservatory/models/orgs_description200_response_rows_inner.rb +263 -0
- data/lib/pharmaobservatory/models/orgs_disease_areas200_response.rb +541 -0
- data/lib/pharmaobservatory/models/orgs_disease_areas200_response_rows_inner.rb +275 -0
- data/lib/pharmaobservatory/models/orgs_diversity200_response.rb +515 -0
- data/lib/pharmaobservatory/models/orgs_diversity200_response_rows_inner.rb +417 -0
- data/lib/pharmaobservatory/models/orgs_esg_trend200_response.rb +529 -0
- data/lib/pharmaobservatory/models/orgs_esg_trend200_response_attribution_inner.rb +275 -0
- data/lib/pharmaobservatory/models/orgs_esg_trend200_response_context.rb +237 -0
- data/lib/pharmaobservatory/models/orgs_esg_trend200_response_rows_inner.rb +405 -0
- data/lib/pharmaobservatory/models/orgs_financial_line_items200_response.rb +529 -0
- data/lib/pharmaobservatory/models/orgs_financial_line_items200_response_context.rb +291 -0
- data/lib/pharmaobservatory/models/orgs_financial_line_items200_response_context_groups_inner.rb +291 -0
- data/lib/pharmaobservatory/models/orgs_financial_line_items200_response_rows_inner.rb +367 -0
- data/lib/pharmaobservatory/models/orgs_financial_overview200_response.rb +529 -0
- data/lib/pharmaobservatory/models/orgs_financial_overview200_response_context.rb +263 -0
- data/lib/pharmaobservatory/models/orgs_financial_overview200_response_rows_inner.rb +275 -0
- data/lib/pharmaobservatory/models/orgs_financial_overview200_response_rows_inner_value.rb +107 -0
- data/lib/pharmaobservatory/models/orgs_financials200_response.rb +541 -0
- data/lib/pharmaobservatory/models/orgs_financials200_response_rows_inner.rb +282 -0
- data/lib/pharmaobservatory/models/orgs_funding200_response.rb +541 -0
- data/lib/pharmaobservatory/models/orgs_funding200_response_context.rb +317 -0
- data/lib/pharmaobservatory/models/orgs_funding200_response_context_summary.rb +367 -0
- data/lib/pharmaobservatory/models/orgs_funding200_response_rows_inner.rb +381 -0
- data/lib/pharmaobservatory/models/orgs_get200_response.rb +423 -0
- data/lib/pharmaobservatory/models/orgs_get200_response_identity.rb +267 -0
- data/lib/pharmaobservatory/models/orgs_get200_response_identity_rows_inner.rb +275 -0
- data/lib/pharmaobservatory/models/orgs_get200_response_identity_rows_inner_value.rb +108 -0
- data/lib/pharmaobservatory/models/orgs_get200_response_sections_inner.rb +417 -0
- data/lib/pharmaobservatory/models/orgs_group_sections200_response.rb +515 -0
- data/lib/pharmaobservatory/models/orgs_group_sections200_response_context.rb +369 -0
- data/lib/pharmaobservatory/models/orgs_group_sections200_response_rows_inner.rb +361 -0
- data/lib/pharmaobservatory/models/orgs_group_structure200_response.rb +515 -0
- data/lib/pharmaobservatory/models/orgs_group_structure200_response_context.rb +275 -0
- data/lib/pharmaobservatory/models/orgs_group_structure200_response_rows_inner.rb +429 -0
- data/lib/pharmaobservatory/models/orgs_gxp_sites200_response.rb +541 -0
- data/lib/pharmaobservatory/models/orgs_gxp_sites200_response_context.rb +283 -0
- data/lib/pharmaobservatory/models/orgs_gxp_sites200_response_context_group_companies_inner.rb +289 -0
- data/lib/pharmaobservatory/models/orgs_gxp_sites200_response_rows_inner.rb +474 -0
- data/lib/pharmaobservatory/models/orgs_gxp_sites_map200_response.rb +529 -0
- data/lib/pharmaobservatory/models/orgs_identity200_response.rb +515 -0
- data/lib/pharmaobservatory/models/orgs_import_refusals200_response.rb +489 -0
- data/lib/pharmaobservatory/models/orgs_institutional13f200_response.rb +555 -0
- data/lib/pharmaobservatory/models/orgs_institutional13f200_response_context.rb +291 -0
- data/lib/pharmaobservatory/models/orgs_institutional13f200_response_rows_inner.rb +684 -0
- data/lib/pharmaobservatory/models/orgs_journals200_response.rb +524 -0
- data/lib/pharmaobservatory/models/orgs_list200_response.rb +527 -0
- data/lib/pharmaobservatory/models/orgs_list200_response_pagination.rb +353 -0
- data/lib/pharmaobservatory/models/orgs_list200_response_query.rb +327 -0
- data/lib/pharmaobservatory/models/orgs_list200_response_rows_inner.rb +507 -0
- data/lib/pharmaobservatory/models/orgs_member_children200_response.rb +489 -0
- data/lib/pharmaobservatory/models/orgs_member_identity200_response.rb +541 -0
- data/lib/pharmaobservatory/models/orgs_member_identity200_response_context.rb +373 -0
- data/lib/pharmaobservatory/models/orgs_member_identity200_response_context_identifiers_inner.rb +289 -0
- data/lib/pharmaobservatory/models/orgs_member_identity200_response_context_parent.rb +289 -0
- data/lib/pharmaobservatory/models/orgs_member_identity200_response_rows_inner.rb +341 -0
- data/lib/pharmaobservatory/models/orgs_member_records200_response.rb +515 -0
- data/lib/pharmaobservatory/models/orgs_member_records200_response_context.rb +239 -0
- data/lib/pharmaobservatory/models/orgs_member_records200_response_rows_inner.rb +289 -0
- data/lib/pharmaobservatory/models/orgs_members200_response.rb +541 -0
- data/lib/pharmaobservatory/models/orgs_members200_response_rows_inner.rb +315 -0
- data/lib/pharmaobservatory/models/orgs_org_assets200_response.rb +529 -0
- data/lib/pharmaobservatory/models/orgs_org_assets200_response_rows_inner.rb +419 -0
- data/lib/pharmaobservatory/models/orgs_org_customer200_response.rb +489 -0
- data/lib/pharmaobservatory/models/orgs_org_customer200_response_rows_inner.rb +237 -0
- data/lib/pharmaobservatory/models/orgs_org_gleif200_response.rb +489 -0
- data/lib/pharmaobservatory/models/orgs_org_gleif200_response_rows_inner.rb +315 -0
- data/lib/pharmaobservatory/models/orgs_org_hosted200_response.rb +489 -0
- data/lib/pharmaobservatory/models/orgs_org_hosted200_response_rows_inner.rb +289 -0
- data/lib/pharmaobservatory/models/orgs_org_owned_drugs200_response.rb +529 -0
- data/lib/pharmaobservatory/models/orgs_org_owned_drugs200_response_rows_inner.rb +395 -0
- data/lib/pharmaobservatory/models/orgs_org_ownership200_response.rb +529 -0
- data/lib/pharmaobservatory/models/orgs_org_ownership200_response_context.rb +324 -0
- data/lib/pharmaobservatory/models/orgs_org_ownership200_response_context_truncated.rb +263 -0
- data/lib/pharmaobservatory/models/orgs_org_patent_mentions200_response.rb +529 -0
- data/lib/pharmaobservatory/models/orgs_org_patent_mentions200_response_attribution_inner.rb +315 -0
- data/lib/pharmaobservatory/models/orgs_org_patent_mentions200_response_rows_inner.rb +367 -0
- data/lib/pharmaobservatory/models/orgs_org_people200_response.rb +555 -0
- data/lib/pharmaobservatory/models/orgs_org_people200_response_context.rb +237 -0
- data/lib/pharmaobservatory/models/orgs_org_people200_response_rows_inner.rb +341 -0
- data/lib/pharmaobservatory/models/orgs_org_pipeline200_response.rb +541 -0
- data/lib/pharmaobservatory/models/orgs_org_pipeline200_response_context.rb +263 -0
- data/lib/pharmaobservatory/models/orgs_org_pipeline200_response_context_counts.rb +289 -0
- data/lib/pharmaobservatory/models/orgs_org_pipeline200_response_rows_inner.rb +367 -0
- data/lib/pharmaobservatory/models/orgs_org_programs200_response.rb +581 -0
- data/lib/pharmaobservatory/models/orgs_org_programs200_response_context.rb +263 -0
- data/lib/pharmaobservatory/models/orgs_org_programs200_response_rows_inner.rb +471 -0
- data/lib/pharmaobservatory/models/orgs_org_publications200_response.rb +529 -0
- data/lib/pharmaobservatory/models/orgs_org_publications200_response_rows_inner.rb +289 -0
- data/lib/pharmaobservatory/models/orgs_org_recruitment200_response.rb +529 -0
- data/lib/pharmaobservatory/models/orgs_org_recruitment200_response_context.rb +757 -0
- data/lib/pharmaobservatory/models/orgs_org_recruitment200_response_context_predicted.rb +259 -0
- data/lib/pharmaobservatory/models/orgs_org_recruitment200_response_context_realized.rb +247 -0
- data/lib/pharmaobservatory/models/orgs_org_recruitment200_response_context_statuses.rb +419 -0
- data/lib/pharmaobservatory/models/orgs_org_relationships200_response.rb +524 -0
- data/lib/pharmaobservatory/models/orgs_org_relationships200_response_query.rb +263 -0
- data/lib/pharmaobservatory/models/orgs_org_supplier200_response.rb +489 -0
- data/lib/pharmaobservatory/models/orgs_org_supplier200_response_rows_inner.rb +285 -0
- data/lib/pharmaobservatory/models/orgs_org_targets200_response.rb +529 -0
- data/lib/pharmaobservatory/models/orgs_org_targets200_response_rows_inner.rb +367 -0
- data/lib/pharmaobservatory/models/orgs_org_type_tally200_response.rb +501 -0
- data/lib/pharmaobservatory/models/orgs_org_type_tally200_response_context.rb +237 -0
- data/lib/pharmaobservatory/models/orgs_org_type_tally200_response_rows_inner.rb +263 -0
- data/lib/pharmaobservatory/models/orgs_org_us_patents200_response.rb +555 -0
- data/lib/pharmaobservatory/models/orgs_org_us_patents200_response_context.rb +327 -0
- data/lib/pharmaobservatory/models/orgs_org_us_patents200_response_rows_inner.rb +315 -0
- data/lib/pharmaobservatory/models/orgs_overview_digest200_response.rb +489 -0
- data/lib/pharmaobservatory/models/orgs_overview_digest200_response_rows_inner.rb +315 -0
- data/lib/pharmaobservatory/models/orgs_ownership_coverage200_response.rb +503 -0
- data/lib/pharmaobservatory/models/orgs_ownership_coverage200_response_rows_inner.rb +483 -0
- data/lib/pharmaobservatory/models/orgs_ownership_history200_response.rb +555 -0
- data/lib/pharmaobservatory/models/orgs_ownership_history200_response_context.rb +249 -0
- data/lib/pharmaobservatory/models/orgs_ownership_history200_response_rows_inner.rb +707 -0
- data/lib/pharmaobservatory/models/orgs_ownership_percentages200_response.rb +529 -0
- data/lib/pharmaobservatory/models/orgs_ownership_percentages200_response_context.rb +315 -0
- data/lib/pharmaobservatory/models/orgs_ownership_percentages200_response_context_insider.rb +495 -0
- data/lib/pharmaobservatory/models/orgs_ownership_percentages200_response_context_institutional.rb +521 -0
- data/lib/pharmaobservatory/models/orgs_ownership_percentages200_response_context_shares_outstanding.rb +367 -0
- data/lib/pharmaobservatory/models/orgs_ownership_percentages200_response_rows_inner.rb +365 -0
- data/lib/pharmaobservatory/models/orgs_ownership_percentages200_response_rows_inner_as_of.rb +105 -0
- data/lib/pharmaobservatory/models/orgs_patent_cliff200_response.rb +529 -0
- data/lib/pharmaobservatory/models/orgs_patent_cliff200_response_context.rb +237 -0
- data/lib/pharmaobservatory/models/orgs_patent_cliff200_response_rows_inner.rb +429 -0
- data/lib/pharmaobservatory/models/orgs_patent_vs_trial200_response.rb +529 -0
- data/lib/pharmaobservatory/models/orgs_patent_vs_trial200_response_context.rb +315 -0
- data/lib/pharmaobservatory/models/orgs_patent_vs_trial200_response_context_portfolio.rb +315 -0
- data/lib/pharmaobservatory/models/orgs_patent_vs_trial200_response_rows_inner.rb +289 -0
- data/lib/pharmaobservatory/models/orgs_patents200_response.rb +515 -0
- data/lib/pharmaobservatory/models/orgs_patents200_response_context.rb +289 -0
- data/lib/pharmaobservatory/models/orgs_patents200_response_rows_inner.rb +289 -0
- data/lib/pharmaobservatory/models/orgs_pdufa_reconciliation200_response.rb +555 -0
- data/lib/pharmaobservatory/models/orgs_pdufa_reconciliation200_response_context.rb +315 -0
- data/lib/pharmaobservatory/models/orgs_pdufa_reconciliation200_response_context_status_counts.rb +289 -0
- data/lib/pharmaobservatory/models/orgs_pdufa_reconciliation200_response_rows_inner.rb +349 -0
- data/lib/pharmaobservatory/models/orgs_peers200_response.rb +489 -0
- data/lib/pharmaobservatory/models/orgs_peers200_response_rows_inner.rb +491 -0
- data/lib/pharmaobservatory/models/orgs_phase_status200_response.rb +529 -0
- data/lib/pharmaobservatory/models/orgs_phase_status200_response_context.rb +237 -0
- data/lib/pharmaobservatory/models/orgs_phase_status200_response_rows_inner.rb +341 -0
- data/lib/pharmaobservatory/models/orgs_publishing_biomarkers200_response.rb +524 -0
- data/lib/pharmaobservatory/models/orgs_publishing_biomarkers200_response_context.rb +289 -0
- data/lib/pharmaobservatory/models/orgs_publishing_biomarkers200_response_context_coverage.rb +315 -0
- data/lib/pharmaobservatory/models/orgs_rare_activity200_response.rb +541 -0
- data/lib/pharmaobservatory/models/orgs_rare_activity200_response_context.rb +237 -0
- data/lib/pharmaobservatory/models/orgs_rare_activity200_response_rows_inner.rb +531 -0
- data/lib/pharmaobservatory/models/orgs_registry_shell200_response.rb +489 -0
- data/lib/pharmaobservatory/models/orgs_registry_shell200_response_rows_inner.rb +263 -0
- data/lib/pharmaobservatory/models/orgs_related_conditions200_response.rb +489 -0
- data/lib/pharmaobservatory/models/orgs_related_conditions200_response_rows_inner.rb +263 -0
- data/lib/pharmaobservatory/models/orgs_related_unfolded200_response.rb +541 -0
- data/lib/pharmaobservatory/models/orgs_related_unfolded200_response_rows_inner.rb +289 -0
- data/lib/pharmaobservatory/models/orgs_revenue_by_drug200_response.rb +529 -0
- data/lib/pharmaobservatory/models/orgs_revenue_by_drug200_response_context.rb +263 -0
- data/lib/pharmaobservatory/models/orgs_revenue_by_drug200_response_rows_inner.rb +315 -0
- data/lib/pharmaobservatory/models/orgs_revenue_geography200_response.rb +529 -0
- data/lib/pharmaobservatory/models/orgs_revenue_geography200_response_context.rb +237 -0
- data/lib/pharmaobservatory/models/orgs_revenue_geography200_response_rows_inner.rb +327 -0
- data/lib/pharmaobservatory/models/orgs_same_name_sec_filer200_response.rb +489 -0
- data/lib/pharmaobservatory/models/orgs_same_name_sec_filer200_response_rows_inner.rb +445 -0
- data/lib/pharmaobservatory/models/orgs_sbti_crosscheck200_response.rb +529 -0
- data/lib/pharmaobservatory/models/orgs_sbti_crosscheck200_response_rows_inner.rb +263 -0
- data/lib/pharmaobservatory/models/orgs_scientist_com200_response.rb +515 -0
- data/lib/pharmaobservatory/models/orgs_scientist_com200_response_context.rb +237 -0
- data/lib/pharmaobservatory/models/orgs_scientist_com200_response_rows_inner.rb +343 -0
- data/lib/pharmaobservatory/models/orgs_sec_filer_shell200_response.rb +489 -0
- data/lib/pharmaobservatory/models/orgs_sec_filer_shell200_response_rows_inner.rb +275 -0
- data/lib/pharmaobservatory/models/orgs_sec_filer_shell200_response_rows_inner_value.rb +108 -0
- data/lib/pharmaobservatory/models/orgs_sec_filer_shell200_response_rows_inner_value_one_of.rb +419 -0
- data/lib/pharmaobservatory/models/orgs_sec_pdufa200_response.rb +503 -0
- data/lib/pharmaobservatory/models/orgs_sec_pdufa200_response_rows_inner.rb +457 -0
- data/lib/pharmaobservatory/models/orgs_supplier_links200_response.rb +475 -0
- data/lib/pharmaobservatory/models/orgs_timeline200_response.rb +541 -0
- data/lib/pharmaobservatory/models/orgs_timeline200_response_rows_inner.rb +346 -0
- data/lib/pharmaobservatory/models/orgs_top_conditions200_response.rb +503 -0
- data/lib/pharmaobservatory/models/orgs_top_conditions200_response_rows_inner.rb +289 -0
- data/lib/pharmaobservatory/models/orgs_top_drugs200_response.rb +503 -0
- data/lib/pharmaobservatory/models/orgs_top_drugs200_response_rows_inner.rb +263 -0
- data/lib/pharmaobservatory/models/orgs_trials_per_year200_response.rb +515 -0
- data/lib/pharmaobservatory/models/orgs_unmatched_revenue200_response.rb +529 -0
- data/lib/pharmaobservatory/models/orgs_unmatched_revenue200_response_rows_inner.rb +289 -0
- data/lib/pharmaobservatory/models/orgs_unmatched_revenue200_response_rows_inner_value.rb +105 -0
- data/lib/pharmaobservatory/version.rb +2 -2
- data/lib/pharmaobservatory.rb +301 -167
- metadata +602 -334
- data/docs/ApiV1BiomarkerAssayScreenApi.md +0 -87
- data/docs/ApiV1BiomarkerAssayScreenGet200Response.md +0 -26
- data/docs/ApiV1BiomarkerAssayScreenGet200ResponseBuildState.md +0 -22
- data/docs/ApiV1BiomarkerAssayScreenGet200ResponseEvidenceInner.md +0 -48
- data/docs/ApiV1BiomarkerAssayScreenGet200ResponseEvidenceInnerSourceRef.md +0 -28
- data/docs/ApiV1BiomarkerAssayScreenGet200ResponseFilters.md +0 -28
- data/docs/ApiV1BiomarkerAssayWhitespaceApi.md +0 -87
- data/docs/ApiV1BiomarkerAssayWhitespaceGet200Response.md +0 -76
- data/docs/ApiV1BiomarkerAssayWhitespaceGet200ResponseBucketCounts.md +0 -34
- data/docs/ApiV1BiomarkerAssayWhitespaceGet200ResponseFilters.md +0 -26
- data/docs/ApiV1BiomarkerAssayWhitespaceGet200ResponseGenesInner.md +0 -38
- data/docs/ApiV1BiomarkerAssayWhitespaceGet200ResponseLiteratureEvidenceInner.md +0 -24
- data/docs/ApiV1BiomarkerAssayWhitespaceGet200ResponseProfileLink.md +0 -20
- data/docs/ApiV1BiomarkerAssayWhitespaceGet200ResponseSupplierDeclarationsInner.md +0 -22
- data/docs/ApiV1BiomarkerAssayWhitespaceGet200ResponseValidatedEvidenceInner.md +0 -34
- data/docs/ApiV1CandidateSiteApi.md +0 -83
- data/docs/ApiV1CandidateSitesGet200Response.md +0 -32
- data/docs/ApiV1CandidateSitesGet200ResponseFilters.md +0 -22
- data/docs/ApiV1CandidateSitesGet200ResponseSitesInner.md +0 -46
- data/docs/ApiV1ConditionApi.md +0 -211
- data/docs/ApiV1ConditionsConditionIdBurdenVsEvidenceGet200Response.md +0 -36
- data/docs/ApiV1ConditionsConditionIdBurdenVsEvidenceGet200ResponseRestriction.md +0 -22
- data/docs/ApiV1ConditionsConditionIdEvidenceFreshnessGet200Response.md +0 -26
- data/docs/ApiV1ConditionsConditionIdEvidenceFreshnessGet200ResponseBuildState.md +0 -18
- data/docs/ApiV1ConditionsConditionIdEvidenceFreshnessGet200ResponseSections.md +0 -20
- data/docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200Response.md +0 -40
- data/docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponseActiveYearSpan.md +0 -20
- data/docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponsePhaseBreakdownInner.md +0 -20
- data/docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponseRecruitmentRollup.md +0 -74
- data/docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponseRecruitmentRollupFiguresInner.md +0 -22
- data/docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponseRecruitmentRollupPhasesInner.md +0 -48
- data/docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponseRecruitmentRollupPredicted.md +0 -24
- data/docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponseRecruitmentRollupRealized.md +0 -22
- data/docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponseRecruitmentRollupStatuses.md +0 -32
- data/docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponseSections.md +0 -28
- data/docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponseSponsorsInner.md +0 -22
- data/docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponseTrialStartForecast.md +0 -32
- data/docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponseTrialsByYearInner.md +0 -20
- data/docs/ApiV1EnrollmentBenchmarkApi.md +0 -79
- data/docs/ApiV1EnrollmentBenchmarkGet200Response.md +0 -28
- data/docs/ApiV1EnrollmentBenchmarkGet200ResponseBenchmark.md +0 -42
- data/docs/ApiV1EnrollmentBenchmarkGet200ResponseBenchmarkAccrualRatePerSiteMonth.md +0 -26
- data/docs/ApiV1EnrollmentBenchmarkGet200ResponseBenchmarkConfidence.md +0 -24
- data/docs/ApiV1EnrollmentBenchmarkGet200ResponseBenchmarkEnrollment.md +0 -22
- data/docs/ApiV1EnrollmentBenchmarkGet200ResponseBenchmarkTypicalDurationMonths.md +0 -28
- data/docs/ApiV1EnrollmentBenchmarkGet200ResponseFilters.md +0 -20
- data/docs/ApiV1InvestorProfileGet200Response.md +0 -38
- data/docs/ApiV1InvestorProfileGet200ResponseFunds.md +0 -20
- data/docs/ApiV1InvestorProfileGet200ResponseFundsRollupInner.md +0 -22
- data/docs/ApiV1InvestorProfileGet200ResponseOwnership.md +0 -22
- data/docs/ApiV1InvestorProfileGet200ResponseOwnershipHoldings.md +0 -22
- data/docs/ApiV1InvestorProfileGet200ResponseOwnershipOwners.md +0 -22
- data/docs/ApiV1InvestorProfileGet200ResponseOwnershipOwnersRowsInner.md +0 -52
- data/docs/ApiV1InvestorProfileGet200ResponseProfile.md +0 -44
- data/docs/ApiV1InvestorProfileGet200ResponseResolution.md +0 -24
- data/docs/ApiV1InvestorProfileGet200ResponseSections.md +0 -24
- data/docs/ApiV1InvestorProfileGet200ResponseSemantics.md +0 -20
- data/docs/ApiV1InvestorProfileGet200ResponseSemanticsOwnershipDimension.md +0 -20
- data/docs/ApiV1InvestorProfileGet200ResponseSemanticsSourceClass.md +0 -18
- data/docs/ApiV1InvestorProfileGet200ResponseSemanticsSourceClassSecFormAdv.md +0 -20
- data/docs/ApiV1LicensingCandidatesGet200Response.md +0 -26
- data/docs/ApiV1LicensingCandidatesGet200ResponseCandidatesInner.md +0 -42
- data/docs/ApiV1OrgFinancingAndOwnershipGet200Response.md +0 -48
- data/docs/ApiV1OrgFinancingAndOwnershipGet200ResponseFinancing.md +0 -24
- data/docs/ApiV1OrgFinancingAndOwnershipGet200ResponseFinancingRoundsInner.md +0 -40
- data/docs/ApiV1OrgFinancingAndOwnershipGet200ResponseFinancingSummary.md +0 -38
- data/docs/ApiV1OrgFinancingAndOwnershipGet200ResponseInvestors.md +0 -26
- data/docs/ApiV1OrgFinancingAndOwnershipGet200ResponseOwnershipPercentages.md +0 -30
- data/docs/ApiV1OrgFinancingAndOwnershipGet200ResponseOwnershipPercentagesInsider.md +0 -40
- data/docs/ApiV1OrgFinancingAndOwnershipGet200ResponseOwnershipPercentagesInstitutional.md +0 -42
- data/docs/ApiV1OrgFinancingAndOwnershipGet200ResponseOwnershipPercentagesNotes.md +0 -30
- data/docs/ApiV1OrgFinancingAndOwnershipGet200ResponseOwnershipPercentagesSharesOutstanding.md +0 -28
- data/docs/ApiV1OrgFinancingAndOwnershipGet200ResponseOwnershipPositions.md +0 -24
- data/docs/ApiV1OrgFinancingAndOwnershipGet200ResponseOwnershipPositionsInstitutional13f.md +0 -22
- data/docs/ApiV1OrgFinancingAndOwnershipGet200ResponseOwnershipPositionsPositionsInner.md +0 -50
- data/docs/ApiV1OrgFinancingAndOwnershipGet200ResponseSections.md +0 -36
- data/docs/ApiV1OrgFinancingAndOwnershipGet200ResponseSemantics.md +0 -20
- data/docs/ApiV1OrgFinancingAndOwnershipGet200ResponseSemanticsOwnershipDimension.md +0 -22
- data/docs/ApiV1OrgFinancingAndOwnershipGet200ResponseSemanticsSourceClass.md +0 -22
- data/docs/ApiV1OrgFinancingAndOwnershipGet200ResponseUnmatchedProductRevenue.md +0 -24
- data/docs/ApiV1OrgFinancingAndOwnershipOwnershipPositionsInstitutional13fHoldersInner.md +0 -34
- data/docs/ApiV1OrgPipelineStagesGet200Response.md +0 -48
- data/docs/ApiV1OrgPipelineStagesGet200ResponseApprovedMarketedInner.md +0 -30
- data/docs/ApiV1OrgPipelineStagesGet200ResponseInDevelopmentInner.md +0 -34
- data/docs/ApiV1OrgPipelineStagesGet200ResponseRecruitmentRollup.md +0 -74
- data/docs/ApiV1OrgPipelineStagesGet200ResponseRecruitmentRollupPhasesInner.md +0 -48
- data/docs/ApiV1OrgPipelineStagesGet200ResponseRecruitmentRollupPredicted.md +0 -24
- data/docs/ApiV1OrgPipelineStagesGet200ResponseSections.md +0 -30
- data/docs/ApiV1OrgPipelineStagesGet200ResponseTrialStartForecast.md +0 -32
- data/docs/ApiV1OrgPipelineStagesGet200ResponseTrialStartForecastYearsInner.md +0 -50
- data/docs/ApiV1OwnershipApi.md +0 -155
- data/docs/ApiV1PatentCliffExposureGet200Response.md +0 -28
- data/docs/ApiV1PatentCliffExposureGet200ResponseExposuresInner.md +0 -46
- data/docs/ApiV1ProgramCatalystApi.md +0 -291
- data/docs/ApiV1ProgramCatalystsGet200Response.md +0 -32
- data/docs/ApiV1ProgramCatalystsGet200ResponseCalendarInner.md +0 -46
- data/docs/ApiV1ProgramCatalystsGet200ResponsePdufa.md +0 -26
- data/docs/ApiV1ProgramCatalystsGet200ResponseSections.md +0 -22
- data/docs/ApiV1ResolveEntityApi.md +0 -83
- data/docs/ApiV1ResolveEntityGet200Response.md +0 -36
- data/docs/ApiV1ResolveEntityGet200ResponseCandidatesInner.md +0 -26
- data/docs/ApiV1ResolveEntityGet200ResponseCandidatesInnerRestriction.md +0 -22
- data/docs/ApiV1ResolveEntityGet200ResponseResolutionConfidence.md +0 -20
- data/docs/ApiV1RwdApi.md +0 -153
- data/docs/ApiV1RwdConductorTrackRecordGet200Response.md +0 -42
- data/docs/ApiV1RwdConductorTrackRecordGet200ResponseConductor.md +0 -28
- data/docs/ApiV1RwdConductorTrackRecordGet200ResponseDeliveryByMandate.md +0 -22
- data/docs/ApiV1RwdConductorTrackRecordGet200ResponseDeliveryByMandateAll.md +0 -52
- data/docs/ApiV1RwdConductorTrackRecordGet200ResponseDeliveryByMandateMandated.md +0 -52
- data/docs/ApiV1RwdConductorTrackRecordGet200ResponseDeliveryByMandateVoluntary.md +0 -52
- data/docs/ApiV1RwdConductorTrackRecordGet200ResponseFootprint.md +0 -20
- data/docs/ApiV1RwdConductorTrackRecordGet200ResponseFootprintDeliveredCountriesInner.md +0 -20
- data/docs/ApiV1RwdStudyScreenGet200Response.md +0 -34
- data/docs/ApiV1RwdStudyScreenGet200ResponseDeliveryDistribution.md +0 -34
- data/docs/ApiV1RwdStudyScreenGet200ResponseFilters.md +0 -24
- data/docs/ApiV1SiteRecordApi.md +0 -83
- data/docs/ApiV1SiteRecordGet200Response.md +0 -36
- data/docs/ApiV1SiteRecordGet200ResponseDetailSections.md +0 -26
- data/docs/ApiV1SiteRecordGet200ResponseDetailSectionsTrials.md +0 -20
- data/docs/ApiV1SiteRecordGet200ResponseSiteKeyRedirect.md +0 -20
- data/docs/ApiV1SiteRecordGet200ResponseSitesInner.md +0 -46
- data/docs/ApiV1SiteRecordGet200ResponseSitesInnerActiveYears.md +0 -20
- data/docs/ApiV1SiteRecordGet200ResponseSitesInnerDrugsInner.md +0 -22
- data/docs/ApiV1SiteRecordGet200ResponseSitesInnerEstimatedEnrollment.md +0 -22
- data/docs/ApiV1SiteRecordGet200ResponseSitesInnerIndicationsInner.md +0 -22
- data/docs/ApiV1SiteRecordGet200ResponseSitesInnerInvestigatorsInner.md +0 -26
- data/docs/ApiV1SiteRecordGet200ResponseSitesInnerTrialsInner.md +0 -24
- data/docs/ApiV1SponsorLandscapeRecruitmentRollupPredictedAtHorizonCap.md +0 -22
- data/docs/ApiV1SponsorLandscapeRecruitmentRollupStatusCountsInner.md +0 -22
- data/docs/ApiV1TrialApi.md +0 -363
- data/docs/ApiV1TrialsDiscontinuationReasonsGet200Response.md +0 -34
- data/docs/ApiV1TrialsDiscontinuationReasonsGet200ResponseFilters.md +0 -20
- data/docs/ApiV1TrialsDiscontinuationReasonsGet200ResponseTrialsInner.md +0 -28
- data/docs/ApiV1TrialsEligibilityGeneralizabilityScanGet200Response.md +0 -32
- data/docs/ApiV1TrialsEligibilityGeneralizabilityScanGet200ResponseFilters.md +0 -18
- data/docs/ApiV1TrialsEligibilityGeneralizabilityScanGet200ResponseTrialsInner.md +0 -32
- data/docs/ApiV1TrialsHistoryAndPredictionGet200Response.md +0 -36
- data/docs/ApiV1TrialsHistoryAndPredictionGet200ResponsePredictionsInner.md +0 -54
- data/docs/ApiV1TrialsHistoryAndPredictionGet200ResponsePredictionsInnerBaseline.md +0 -24
- data/docs/ApiV1TrialsHistoryAndPredictionGet200ResponsePredictionsInnerFigure.md +0 -28
- data/docs/ApiV1TrialsHistoryAndPredictionGet200ResponsePredictionsInnerInputsAsRegistered.md +0 -38
- data/docs/ApiV1TrialsHistoryAndPredictionGet200ResponsePredictionsInnerMeasuredError.md +0 -26
- data/docs/ApiV1TrialsHistoryAndPredictionGet200ResponsePredictionsInnerMeasuredErrorPhase.md +0 -34
- data/docs/ApiV1TrialsHistoryAndPredictionGet200ResponsePredictionsInnerMeasuredErrorSize.md +0 -34
- data/docs/ApiV1TrialsHistoryAndPredictionGet200ResponsePredictionsInnerReason.md +0 -28
- data/docs/ApiV1TrialsHistoryAndPredictionGet200ResponsePredictionsStatus.md +0 -28
- data/docs/ApiV1TrialsHistoryAndPredictionGet200ResponseRecordHistory.md +0 -36
- data/docs/ApiV1TrialsHistoryAndPredictionGet200ResponseRecordHistoryChangesInner.md +0 -24
- data/docs/ApiV1TrialsHistoryAndPredictionGet200ResponseRecordHistoryObservationsInner.md +0 -32
- data/docs/ApiV1TrialsHistoryAndPredictionGet200ResponseRecordHistoryObservationsInnerEnrollment.md +0 -28
- data/docs/ApiV1TrialsHistoryAndPredictionGet200ResponseRecordHistoryObservationsInnerSites.md +0 -32
- data/docs/ApiV1TrialsHistoryAndPredictionGet200ResponseRecordHistoryObservationsInnerStartDate.md +0 -28
- data/docs/ApiV1TrialsHistoryAndPredictionGet200ResponseSections.md +0 -26
- data/docs/ApiV1TrialsHistoryPredictionsInnerRegisteredPrimaryCompletion.md +0 -22
- data/docs/ApiV1TrialsHistoryRecordHistoryObservationsInnerOverallStatus.md +0 -24
- data/docs/ApiV1TrialsRecordsGet200Response.md +0 -28
- data/docs/ApiV1TrialsRecordsGet200ResponseBuildState.md +0 -22
- data/docs/ApiV1TrialsRecordsGet200ResponseExtractionCoverage.md +0 -32
- data/docs/ApiV1TrialsRecordsGet200ResponseSections.md +0 -20
- data/docs/ApiV1TrialsRecordsGet200ResponseSectionsExtracted.md +0 -22
- data/docs/ApiV1TrialsRecordsGet200ResponseTrialsInner.md +0 -114
- data/docs/ApiV1TrialsRecordsGet200ResponseTrialsInnerExtracted.md +0 -46
- data/docs/ApiV1TrialsRecordsGet200ResponseTrialsInnerLinkedDrugsInner.md +0 -28
- data/docs/ApiV1TrialsRecordsGet200ResponseTrialsInnerLinkedDrugsInnerBrandsInner.md +0 -20
- data/docs/ApiV1TrialsReportingCompletenessGet200Response.md +0 -32
- data/docs/ApiV1TrialsReportingCompletenessGet200ResponseDemographicFieldPopulationRate.md +0 -24
- data/lib/pharmaobservatory/api/api_v1_biomarker_assay_screen_api.rb +0 -95
- data/lib/pharmaobservatory/api/api_v1_biomarker_assay_whitespace_api.rb +0 -95
- data/lib/pharmaobservatory/api/api_v1_candidate_site_api.rb +0 -89
- data/lib/pharmaobservatory/api/api_v1_condition_api.rb +0 -205
- data/lib/pharmaobservatory/api/api_v1_enrollment_benchmark_api.rb +0 -83
- data/lib/pharmaobservatory/api/api_v1_ownership_api.rb +0 -150
- data/lib/pharmaobservatory/api/api_v1_program_catalyst_api.rb +0 -260
- data/lib/pharmaobservatory/api/api_v1_resolve_entity_api.rb +0 -89
- data/lib/pharmaobservatory/api/api_v1_rwd_api.rb +0 -147
- data/lib/pharmaobservatory/api/api_v1_site_record_api.rb +0 -89
- data/lib/pharmaobservatory/api/api_v1_trial_api.rb +0 -321
- data/lib/pharmaobservatory/models/api_v1_biomarker_assay_screen_get200_response.rb +0 -343
- data/lib/pharmaobservatory/models/api_v1_biomarker_assay_screen_get200_response_build_state.rb +0 -275
- data/lib/pharmaobservatory/models/api_v1_biomarker_assay_screen_get200_response_evidence_inner.rb +0 -507
- data/lib/pharmaobservatory/models/api_v1_biomarker_assay_screen_get200_response_evidence_inner_source_ref.rb +0 -369
- data/lib/pharmaobservatory/models/api_v1_biomarker_assay_screen_get200_response_filters.rb +0 -283
- data/lib/pharmaobservatory/models/api_v1_biomarker_assay_whitespace_get200_response.rb +0 -525
- data/lib/pharmaobservatory/models/api_v1_biomarker_assay_whitespace_get200_response_bucket_counts.rb +0 -445
- data/lib/pharmaobservatory/models/api_v1_biomarker_assay_whitespace_get200_response_filters.rb +0 -285
- data/lib/pharmaobservatory/models/api_v1_biomarker_assay_whitespace_get200_response_genes_inner.rb +0 -469
- data/lib/pharmaobservatory/models/api_v1_biomarker_assay_whitespace_get200_response_literature_evidence_inner.rb +0 -317
- data/lib/pharmaobservatory/models/api_v1_biomarker_assay_whitespace_get200_response_profile_link.rb +0 -263
- data/lib/pharmaobservatory/models/api_v1_biomarker_assay_whitespace_get200_response_supplier_declarations_inner.rb +0 -289
- data/lib/pharmaobservatory/models/api_v1_biomarker_assay_whitespace_get200_response_validated_evidence_inner.rb +0 -431
- data/lib/pharmaobservatory/models/api_v1_candidate_sites_get200_response.rb +0 -302
- data/lib/pharmaobservatory/models/api_v1_candidate_sites_get200_response_filters.rb +0 -289
- data/lib/pharmaobservatory/models/api_v1_candidate_sites_get200_response_sites_inner.rb +0 -573
- data/lib/pharmaobservatory/models/api_v1_conditions_condition_id_burden_vs_evidence_get200_response.rb +0 -471
- data/lib/pharmaobservatory/models/api_v1_conditions_condition_id_burden_vs_evidence_get200_response_restriction.rb +0 -289
- data/lib/pharmaobservatory/models/api_v1_conditions_condition_id_evidence_freshness_get200_response.rb +0 -327
- data/lib/pharmaobservatory/models/api_v1_conditions_condition_id_evidence_freshness_get200_response_build_state.rb +0 -237
- data/lib/pharmaobservatory/models/api_v1_conditions_condition_id_evidence_freshness_get200_response_sections.rb +0 -263
- data/lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response.rb +0 -398
- data/lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_active_year_span.rb +0 -235
- data/lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_phase_breakdown_inner.rb +0 -263
- data/lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_recruitment_rollup.rb +0 -954
- data/lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_recruitment_rollup_figures_inner.rb +0 -289
- data/lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_recruitment_rollup_phases_inner.rb +0 -512
- data/lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_recruitment_rollup_predicted.rb +0 -259
- data/lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_recruitment_rollup_realized.rb +0 -289
- data/lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_recruitment_rollup_statuses.rb +0 -419
- data/lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_sections.rb +0 -299
- data/lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_sponsors_inner.rb +0 -289
- data/lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_trial_start_forecast.rb +0 -421
- data/lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_trials_by_year_inner.rb +0 -263
- data/lib/pharmaobservatory/models/api_v1_enrollment_benchmark_get200_response.rb +0 -282
- data/lib/pharmaobservatory/models/api_v1_enrollment_benchmark_get200_response_benchmark.rb +0 -549
- data/lib/pharmaobservatory/models/api_v1_enrollment_benchmark_get200_response_benchmark_accrual_rate_per_site_month.rb +0 -341
- data/lib/pharmaobservatory/models/api_v1_enrollment_benchmark_get200_response_benchmark_confidence.rb +0 -301
- data/lib/pharmaobservatory/models/api_v1_enrollment_benchmark_get200_response_benchmark_enrollment.rb +0 -289
- data/lib/pharmaobservatory/models/api_v1_enrollment_benchmark_get200_response_benchmark_typical_duration_months.rb +0 -367
- data/lib/pharmaobservatory/models/api_v1_enrollment_benchmark_get200_response_filters.rb +0 -263
- data/lib/pharmaobservatory/models/api_v1_investor_profile_get200_response.rb +0 -401
- data/lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_funds.rb +0 -265
- data/lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_funds_rollup_inner.rb +0 -289
- data/lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_ownership.rb +0 -289
- data/lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_ownership_holdings.rb +0 -291
- data/lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_ownership_owners.rb +0 -291
- data/lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_ownership_owners_rows_inner.rb +0 -595
- data/lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_profile.rb +0 -561
- data/lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_resolution.rb +0 -303
- data/lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_sections.rb +0 -315
- data/lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_semantics.rb +0 -263
- data/lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_semantics_ownership_dimension.rb +0 -229
- data/lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_semantics_source_class.rb +0 -220
- data/lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_semantics_source_class_sec_form_adv.rb +0 -263
- data/lib/pharmaobservatory/models/api_v1_licensing_candidates_get200_response.rb +0 -343
- data/lib/pharmaobservatory/models/api_v1_licensing_candidates_get200_response_candidates_inner.rb +0 -549
- data/lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response.rb +0 -481
- data/lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_financing.rb +0 -303
- data/lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_financing_rounds_inner.rb +0 -509
- data/lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_financing_summary.rb +0 -497
- data/lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_investors.rb +0 -343
- data/lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_ownership_percentages.rb +0 -365
- data/lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_ownership_percentages_insider.rb +0 -453
- data/lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_ownership_percentages_institutional.rb +0 -437
- data/lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_ownership_percentages_notes.rb +0 -393
- data/lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_ownership_percentages_shares_outstanding.rb +0 -339
- data/lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_ownership_positions.rb +0 -317
- data/lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_ownership_positions_institutional13f.rb +0 -291
- data/lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_ownership_positions_positions_inner.rb +0 -597
- data/lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_sections.rb +0 -403
- data/lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_semantics.rb +0 -263
- data/lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_semantics_ownership_dimension.rb +0 -238
- data/lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_semantics_source_class.rb +0 -238
- data/lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_unmatched_product_revenue.rb +0 -301
- data/lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_ownership_positions_institutional13f_holders_inner.rb +0 -417
- data/lib/pharmaobservatory/models/api_v1_org_pipeline_stages_get200_response.rb +0 -449
- data/lib/pharmaobservatory/models/api_v1_org_pipeline_stages_get200_response_approved_marketed_inner.rb +0 -393
- data/lib/pharmaobservatory/models/api_v1_org_pipeline_stages_get200_response_in_development_inner.rb +0 -445
- data/lib/pharmaobservatory/models/api_v1_org_pipeline_stages_get200_response_recruitment_rollup.rb +0 -940
- data/lib/pharmaobservatory/models/api_v1_org_pipeline_stages_get200_response_recruitment_rollup_phases_inner.rb +0 -512
- data/lib/pharmaobservatory/models/api_v1_org_pipeline_stages_get200_response_recruitment_rollup_predicted.rb +0 -315
- data/lib/pharmaobservatory/models/api_v1_org_pipeline_stages_get200_response_sections.rb +0 -325
- data/lib/pharmaobservatory/models/api_v1_org_pipeline_stages_get200_response_trial_start_forecast.rb +0 -421
- data/lib/pharmaobservatory/models/api_v1_org_pipeline_stages_get200_response_trial_start_forecast_years_inner.rb +0 -611
- data/lib/pharmaobservatory/models/api_v1_patent_cliff_exposure_get200_response.rb +0 -339
- data/lib/pharmaobservatory/models/api_v1_patent_cliff_exposure_get200_response_exposures_inner.rb +0 -531
- data/lib/pharmaobservatory/models/api_v1_program_catalysts_get200_response.rb +0 -377
- data/lib/pharmaobservatory/models/api_v1_program_catalysts_get200_response_calendar_inner.rb +0 -429
- data/lib/pharmaobservatory/models/api_v1_program_catalysts_get200_response_pdufa.rb +0 -324
- data/lib/pharmaobservatory/models/api_v1_program_catalysts_get200_response_sections.rb +0 -289
- data/lib/pharmaobservatory/models/api_v1_resolve_entity_get200_response.rb +0 -383
- data/lib/pharmaobservatory/models/api_v1_resolve_entity_get200_response_candidates_inner.rb +0 -283
- data/lib/pharmaobservatory/models/api_v1_resolve_entity_get200_response_candidates_inner_restriction.rb +0 -289
- data/lib/pharmaobservatory/models/api_v1_resolve_entity_get200_response_resolution_confidence.rb +0 -249
- data/lib/pharmaobservatory/models/api_v1_rwd_conductor_track_record_get200_response.rb +0 -467
- data/lib/pharmaobservatory/models/api_v1_rwd_conductor_track_record_get200_response_conductor.rb +0 -371
- data/lib/pharmaobservatory/models/api_v1_rwd_conductor_track_record_get200_response_delivery_by_mandate.rb +0 -272
- data/lib/pharmaobservatory/models/api_v1_rwd_conductor_track_record_get200_response_delivery_by_mandate_all.rb +0 -595
- data/lib/pharmaobservatory/models/api_v1_rwd_conductor_track_record_get200_response_delivery_by_mandate_mandated.rb +0 -609
- data/lib/pharmaobservatory/models/api_v1_rwd_conductor_track_record_get200_response_delivery_by_mandate_voluntary.rb +0 -665
- data/lib/pharmaobservatory/models/api_v1_rwd_conductor_track_record_get200_response_footprint.rb +0 -267
- data/lib/pharmaobservatory/models/api_v1_rwd_conductor_track_record_get200_response_footprint_delivered_countries_inner.rb +0 -263
- data/lib/pharmaobservatory/models/api_v1_rwd_study_screen_get200_response.rb +0 -387
- data/lib/pharmaobservatory/models/api_v1_rwd_study_screen_get200_response_delivery_distribution.rb +0 -403
- data/lib/pharmaobservatory/models/api_v1_rwd_study_screen_get200_response_filters.rb +0 -259
- data/lib/pharmaobservatory/models/api_v1_site_record_get200_response.rb +0 -320
- data/lib/pharmaobservatory/models/api_v1_site_record_get200_response_detail_sections.rb +0 -341
- data/lib/pharmaobservatory/models/api_v1_site_record_get200_response_detail_sections_trials.rb +0 -265
- data/lib/pharmaobservatory/models/api_v1_site_record_get200_response_site_key_redirect.rb +0 -263
- data/lib/pharmaobservatory/models/api_v1_site_record_get200_response_sites_inner.rb +0 -477
- data/lib/pharmaobservatory/models/api_v1_site_record_get200_response_sites_inner_active_years.rb +0 -235
- data/lib/pharmaobservatory/models/api_v1_site_record_get200_response_sites_inner_drugs_inner.rb +0 -289
- data/lib/pharmaobservatory/models/api_v1_site_record_get200_response_sites_inner_estimated_enrollment.rb +0 -289
- data/lib/pharmaobservatory/models/api_v1_site_record_get200_response_sites_inner_indications_inner.rb +0 -289
- data/lib/pharmaobservatory/models/api_v1_site_record_get200_response_sites_inner_investigators_inner.rb +0 -327
- data/lib/pharmaobservatory/models/api_v1_site_record_get200_response_sites_inner_trials_inner.rb +0 -301
- data/lib/pharmaobservatory/models/api_v1_sponsor_landscape_recruitment_rollup_predicted_at_horizon_cap.rb +0 -289
- data/lib/pharmaobservatory/models/api_v1_sponsor_landscape_recruitment_rollup_status_counts_inner.rb +0 -289
- data/lib/pharmaobservatory/models/api_v1_trials_discontinuation_reasons_get200_response.rb +0 -311
- data/lib/pharmaobservatory/models/api_v1_trials_discontinuation_reasons_get200_response_filters.rb +0 -265
- data/lib/pharmaobservatory/models/api_v1_trials_discontinuation_reasons_get200_response_trials_inner.rb +0 -353
- data/lib/pharmaobservatory/models/api_v1_trials_eligibility_generalizability_scan_get200_response.rb +0 -302
- data/lib/pharmaobservatory/models/api_v1_trials_eligibility_generalizability_scan_get200_response_filters.rb +0 -237
- data/lib/pharmaobservatory/models/api_v1_trials_eligibility_generalizability_scan_get200_response_trials_inner.rb +0 -351
- data/lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response.rb +0 -340
- data/lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_predictions_inner.rb +0 -579
- data/lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_predictions_inner_baseline.rb +0 -315
- data/lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_predictions_inner_figure.rb +0 -367
- data/lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_predictions_inner_inputs_as_registered.rb +0 -343
- data/lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_predictions_inner_measured_error.rb +0 -299
- data/lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_predictions_inner_measured_error_phase.rb +0 -361
- data/lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_predictions_inner_measured_error_size.rb +0 -375
- data/lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_predictions_inner_reason.rb +0 -311
- data/lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_predictions_status.rb +0 -311
- data/lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_record_history.rb +0 -433
- data/lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_record_history_changes_inner.rb +0 -315
- data/lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_record_history_observations_inner.rb +0 -419
- data/lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_record_history_observations_inner_enrollment.rb +0 -311
- data/lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_record_history_observations_inner_sites.rb +0 -321
- data/lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_record_history_observations_inner_start_date.rb +0 -311
- data/lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_sections.rb +0 -273
- data/lib/pharmaobservatory/models/api_v1_trials_history_predictions_inner_registered_primary_completion.rb +0 -261
- data/lib/pharmaobservatory/models/api_v1_trials_history_record_history_observations_inner_overall_status.rb +0 -287
- data/lib/pharmaobservatory/models/api_v1_trials_records_get200_response.rb +0 -339
- data/lib/pharmaobservatory/models/api_v1_trials_records_get200_response_build_state.rb +0 -256
- data/lib/pharmaobservatory/models/api_v1_trials_records_get200_response_extraction_coverage.rb +0 -300
- data/lib/pharmaobservatory/models/api_v1_trials_records_get200_response_sections.rb +0 -263
- data/lib/pharmaobservatory/models/api_v1_trials_records_get200_response_sections_extracted.rb +0 -275
- data/lib/pharmaobservatory/models/api_v1_trials_records_get200_response_trials_inner.rb +0 -1189
- data/lib/pharmaobservatory/models/api_v1_trials_records_get200_response_trials_inner_extracted.rb +0 -382
- data/lib/pharmaobservatory/models/api_v1_trials_records_get200_response_trials_inner_linked_drugs_inner.rb +0 -343
- data/lib/pharmaobservatory/models/api_v1_trials_records_get200_response_trials_inner_linked_drugs_inner_brands_inner.rb +0 -263
- data/lib/pharmaobservatory/models/api_v1_trials_reporting_completeness_get200_response.rb +0 -300
- data/lib/pharmaobservatory/models/api_v1_trials_reporting_completeness_get200_response_demographic_field_population_rate.rb +0 -315
metadata
CHANGED
|
@@ -1,14 +1,14 @@
|
|
|
1
1
|
--- !ruby/object:Gem::Specification
|
|
2
2
|
name: pharmaobservatory
|
|
3
3
|
version: !ruby/object:Gem::Version
|
|
4
|
-
version: 0.1.
|
|
4
|
+
version: 0.1.2
|
|
5
5
|
platform: ruby
|
|
6
6
|
authors:
|
|
7
7
|
- Scientist.com
|
|
8
8
|
autorequire:
|
|
9
9
|
bindir: bin
|
|
10
10
|
cert_chain: []
|
|
11
|
-
date: 2026-10-
|
|
11
|
+
date: 2026-10-18 00:00:00.000000000 Z
|
|
12
12
|
dependencies:
|
|
13
13
|
- !ruby/object:Gem::Dependency
|
|
14
14
|
name: faraday
|
|
@@ -88,349 +88,617 @@ extra_rdoc_files: []
|
|
|
88
88
|
files:
|
|
89
89
|
- README.md
|
|
90
90
|
- docs/ApiV1BaseApi.md
|
|
91
|
-
- docs/ApiV1BiomarkerAssayScreenApi.md
|
|
92
|
-
- docs/ApiV1BiomarkerAssayScreenGet200Response.md
|
|
93
|
-
- docs/ApiV1BiomarkerAssayScreenGet200ResponseBuildState.md
|
|
94
|
-
- docs/ApiV1BiomarkerAssayScreenGet200ResponseEvidenceInner.md
|
|
95
|
-
- docs/ApiV1BiomarkerAssayScreenGet200ResponseEvidenceInnerSourceRef.md
|
|
96
|
-
- docs/ApiV1BiomarkerAssayScreenGet200ResponseFilters.md
|
|
97
|
-
- docs/ApiV1BiomarkerAssayWhitespaceApi.md
|
|
98
|
-
- docs/ApiV1BiomarkerAssayWhitespaceGet200Response.md
|
|
99
|
-
- docs/ApiV1BiomarkerAssayWhitespaceGet200ResponseBucketCounts.md
|
|
100
|
-
- docs/ApiV1BiomarkerAssayWhitespaceGet200ResponseFilters.md
|
|
101
|
-
- docs/ApiV1BiomarkerAssayWhitespaceGet200ResponseGenesInner.md
|
|
102
|
-
- docs/ApiV1BiomarkerAssayWhitespaceGet200ResponseLiteratureEvidenceInner.md
|
|
103
|
-
- docs/ApiV1BiomarkerAssayWhitespaceGet200ResponseProfileLink.md
|
|
104
|
-
- docs/ApiV1BiomarkerAssayWhitespaceGet200ResponseSupplierDeclarationsInner.md
|
|
105
|
-
- docs/ApiV1BiomarkerAssayWhitespaceGet200ResponseValidatedEvidenceInner.md
|
|
106
|
-
- docs/ApiV1CandidateSiteApi.md
|
|
107
|
-
- docs/ApiV1CandidateSitesGet200Response.md
|
|
108
|
-
- docs/ApiV1CandidateSitesGet200ResponseFilters.md
|
|
109
|
-
- docs/ApiV1CandidateSitesGet200ResponseSitesInner.md
|
|
110
|
-
- docs/ApiV1ConditionApi.md
|
|
111
|
-
- docs/ApiV1ConditionsConditionIdBurdenVsEvidenceGet200Response.md
|
|
112
|
-
- docs/ApiV1ConditionsConditionIdBurdenVsEvidenceGet200ResponseRestriction.md
|
|
113
|
-
- docs/ApiV1ConditionsConditionIdEvidenceFreshnessGet200Response.md
|
|
114
|
-
- docs/ApiV1ConditionsConditionIdEvidenceFreshnessGet200ResponseBuildState.md
|
|
115
|
-
- docs/ApiV1ConditionsConditionIdEvidenceFreshnessGet200ResponseSections.md
|
|
116
|
-
- docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200Response.md
|
|
117
|
-
- docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponseActiveYearSpan.md
|
|
118
|
-
- docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponsePhaseBreakdownInner.md
|
|
119
|
-
- docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponseRecruitmentRollup.md
|
|
120
|
-
- docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponseRecruitmentRollupFiguresInner.md
|
|
121
|
-
- docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponseRecruitmentRollupPhasesInner.md
|
|
122
|
-
- docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponseRecruitmentRollupPredicted.md
|
|
123
|
-
- docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponseRecruitmentRollupRealized.md
|
|
124
|
-
- docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponseRecruitmentRollupStatuses.md
|
|
125
|
-
- docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponseSections.md
|
|
126
|
-
- docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponseSponsorsInner.md
|
|
127
|
-
- docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponseTrialStartForecast.md
|
|
128
|
-
- docs/ApiV1ConditionsConditionIdSponsorLandscapeGet200ResponseTrialsByYearInner.md
|
|
129
|
-
- docs/ApiV1EnrollmentBenchmarkApi.md
|
|
130
|
-
- docs/ApiV1EnrollmentBenchmarkGet200Response.md
|
|
131
|
-
- docs/ApiV1EnrollmentBenchmarkGet200ResponseBenchmark.md
|
|
132
|
-
- docs/ApiV1EnrollmentBenchmarkGet200ResponseBenchmarkAccrualRatePerSiteMonth.md
|
|
133
|
-
- docs/ApiV1EnrollmentBenchmarkGet200ResponseBenchmarkConfidence.md
|
|
134
|
-
- docs/ApiV1EnrollmentBenchmarkGet200ResponseBenchmarkEnrollment.md
|
|
135
|
-
- docs/ApiV1EnrollmentBenchmarkGet200ResponseBenchmarkTypicalDurationMonths.md
|
|
136
|
-
- docs/ApiV1EnrollmentBenchmarkGet200ResponseFilters.md
|
|
137
|
-
- docs/ApiV1InvestorProfileGet200Response.md
|
|
138
|
-
- docs/ApiV1InvestorProfileGet200ResponseFunds.md
|
|
139
|
-
- docs/ApiV1InvestorProfileGet200ResponseFundsRollupInner.md
|
|
140
|
-
- docs/ApiV1InvestorProfileGet200ResponseOwnership.md
|
|
141
|
-
- docs/ApiV1InvestorProfileGet200ResponseOwnershipHoldings.md
|
|
142
|
-
- docs/ApiV1InvestorProfileGet200ResponseOwnershipOwners.md
|
|
143
|
-
- docs/ApiV1InvestorProfileGet200ResponseOwnershipOwnersRowsInner.md
|
|
144
|
-
- docs/ApiV1InvestorProfileGet200ResponseProfile.md
|
|
145
|
-
- docs/ApiV1InvestorProfileGet200ResponseResolution.md
|
|
146
|
-
- docs/ApiV1InvestorProfileGet200ResponseSections.md
|
|
147
|
-
- docs/ApiV1InvestorProfileGet200ResponseSemantics.md
|
|
148
|
-
- docs/ApiV1InvestorProfileGet200ResponseSemanticsOwnershipDimension.md
|
|
149
|
-
- docs/ApiV1InvestorProfileGet200ResponseSemanticsSourceClass.md
|
|
150
|
-
- docs/ApiV1InvestorProfileGet200ResponseSemanticsSourceClassSecFormAdv.md
|
|
151
|
-
- docs/ApiV1LicensingCandidatesGet200Response.md
|
|
152
|
-
- docs/ApiV1LicensingCandidatesGet200ResponseCandidatesInner.md
|
|
153
|
-
- docs/ApiV1OrgFinancingAndOwnershipGet200Response.md
|
|
154
|
-
- docs/ApiV1OrgFinancingAndOwnershipGet200ResponseFinancing.md
|
|
155
|
-
- docs/ApiV1OrgFinancingAndOwnershipGet200ResponseFinancingRoundsInner.md
|
|
156
|
-
- docs/ApiV1OrgFinancingAndOwnershipGet200ResponseFinancingSummary.md
|
|
157
|
-
- docs/ApiV1OrgFinancingAndOwnershipGet200ResponseInvestors.md
|
|
158
|
-
- docs/ApiV1OrgFinancingAndOwnershipGet200ResponseOwnershipPercentages.md
|
|
159
|
-
- docs/ApiV1OrgFinancingAndOwnershipGet200ResponseOwnershipPercentagesInsider.md
|
|
160
|
-
- docs/ApiV1OrgFinancingAndOwnershipGet200ResponseOwnershipPercentagesInstitutional.md
|
|
161
|
-
- docs/ApiV1OrgFinancingAndOwnershipGet200ResponseOwnershipPercentagesNotes.md
|
|
162
|
-
- docs/ApiV1OrgFinancingAndOwnershipGet200ResponseOwnershipPercentagesSharesOutstanding.md
|
|
163
|
-
- docs/ApiV1OrgFinancingAndOwnershipGet200ResponseOwnershipPositions.md
|
|
164
|
-
- docs/ApiV1OrgFinancingAndOwnershipGet200ResponseOwnershipPositionsInstitutional13f.md
|
|
165
|
-
- docs/ApiV1OrgFinancingAndOwnershipGet200ResponseOwnershipPositionsPositionsInner.md
|
|
166
|
-
- docs/ApiV1OrgFinancingAndOwnershipGet200ResponseSections.md
|
|
167
|
-
- docs/ApiV1OrgFinancingAndOwnershipGet200ResponseSemantics.md
|
|
168
|
-
- docs/ApiV1OrgFinancingAndOwnershipGet200ResponseSemanticsOwnershipDimension.md
|
|
169
|
-
- docs/ApiV1OrgFinancingAndOwnershipGet200ResponseSemanticsSourceClass.md
|
|
170
|
-
- docs/ApiV1OrgFinancingAndOwnershipGet200ResponseUnmatchedProductRevenue.md
|
|
171
|
-
- docs/ApiV1OrgFinancingAndOwnershipOwnershipPositionsInstitutional13fHoldersInner.md
|
|
172
|
-
- docs/ApiV1OrgPipelineStagesGet200Response.md
|
|
173
|
-
- docs/ApiV1OrgPipelineStagesGet200ResponseApprovedMarketedInner.md
|
|
174
|
-
- docs/ApiV1OrgPipelineStagesGet200ResponseInDevelopmentInner.md
|
|
175
|
-
- docs/ApiV1OrgPipelineStagesGet200ResponseRecruitmentRollup.md
|
|
176
|
-
- docs/ApiV1OrgPipelineStagesGet200ResponseRecruitmentRollupPhasesInner.md
|
|
177
|
-
- docs/ApiV1OrgPipelineStagesGet200ResponseRecruitmentRollupPredicted.md
|
|
178
|
-
- docs/ApiV1OrgPipelineStagesGet200ResponseSections.md
|
|
179
|
-
- docs/ApiV1OrgPipelineStagesGet200ResponseTrialStartForecast.md
|
|
180
|
-
- docs/ApiV1OrgPipelineStagesGet200ResponseTrialStartForecastYearsInner.md
|
|
181
|
-
- docs/ApiV1OwnershipApi.md
|
|
182
|
-
- docs/ApiV1PatentCliffExposureGet200Response.md
|
|
183
|
-
- docs/ApiV1PatentCliffExposureGet200ResponseExposuresInner.md
|
|
184
|
-
- docs/ApiV1ProgramCatalystApi.md
|
|
185
|
-
- docs/ApiV1ProgramCatalystsGet200Response.md
|
|
186
|
-
- docs/ApiV1ProgramCatalystsGet200ResponseCalendarInner.md
|
|
187
|
-
- docs/ApiV1ProgramCatalystsGet200ResponsePdufa.md
|
|
188
|
-
- docs/ApiV1ProgramCatalystsGet200ResponseSections.md
|
|
189
|
-
- docs/ApiV1ResolveEntityApi.md
|
|
190
|
-
- docs/ApiV1ResolveEntityGet200Response.md
|
|
191
|
-
- docs/ApiV1ResolveEntityGet200ResponseCandidatesInner.md
|
|
192
|
-
- docs/ApiV1ResolveEntityGet200ResponseCandidatesInnerRestriction.md
|
|
193
|
-
- docs/ApiV1ResolveEntityGet200ResponseResolutionConfidence.md
|
|
194
|
-
- docs/ApiV1RwdApi.md
|
|
195
|
-
- docs/ApiV1RwdConductorTrackRecordGet200Response.md
|
|
196
|
-
- docs/ApiV1RwdConductorTrackRecordGet200ResponseConductor.md
|
|
197
|
-
- docs/ApiV1RwdConductorTrackRecordGet200ResponseDeliveryByMandate.md
|
|
198
|
-
- docs/ApiV1RwdConductorTrackRecordGet200ResponseDeliveryByMandateAll.md
|
|
199
|
-
- docs/ApiV1RwdConductorTrackRecordGet200ResponseDeliveryByMandateMandated.md
|
|
200
|
-
- docs/ApiV1RwdConductorTrackRecordGet200ResponseDeliveryByMandateVoluntary.md
|
|
201
|
-
- docs/ApiV1RwdConductorTrackRecordGet200ResponseFootprint.md
|
|
202
|
-
- docs/ApiV1RwdConductorTrackRecordGet200ResponseFootprintDeliveredCountriesInner.md
|
|
203
|
-
- docs/ApiV1RwdStudyScreenGet200Response.md
|
|
204
|
-
- docs/ApiV1RwdStudyScreenGet200ResponseDeliveryDistribution.md
|
|
205
|
-
- docs/ApiV1RwdStudyScreenGet200ResponseFilters.md
|
|
206
|
-
- docs/ApiV1SiteRecordApi.md
|
|
207
|
-
- docs/ApiV1SiteRecordGet200Response.md
|
|
208
|
-
- docs/ApiV1SiteRecordGet200ResponseDetailSections.md
|
|
209
|
-
- docs/ApiV1SiteRecordGet200ResponseDetailSectionsTrials.md
|
|
210
|
-
- docs/ApiV1SiteRecordGet200ResponseSiteKeyRedirect.md
|
|
211
|
-
- docs/ApiV1SiteRecordGet200ResponseSitesInner.md
|
|
212
|
-
- docs/ApiV1SiteRecordGet200ResponseSitesInnerActiveYears.md
|
|
213
|
-
- docs/ApiV1SiteRecordGet200ResponseSitesInnerDrugsInner.md
|
|
214
|
-
- docs/ApiV1SiteRecordGet200ResponseSitesInnerEstimatedEnrollment.md
|
|
215
|
-
- docs/ApiV1SiteRecordGet200ResponseSitesInnerIndicationsInner.md
|
|
216
|
-
- docs/ApiV1SiteRecordGet200ResponseSitesInnerInvestigatorsInner.md
|
|
217
|
-
- docs/ApiV1SiteRecordGet200ResponseSitesInnerTrialsInner.md
|
|
218
|
-
- docs/ApiV1SponsorLandscapeRecruitmentRollupPredictedAtHorizonCap.md
|
|
219
|
-
- docs/ApiV1SponsorLandscapeRecruitmentRollupStatusCountsInner.md
|
|
220
|
-
- docs/ApiV1TrialApi.md
|
|
221
|
-
- docs/ApiV1TrialsDiscontinuationReasonsGet200Response.md
|
|
222
|
-
- docs/ApiV1TrialsDiscontinuationReasonsGet200ResponseFilters.md
|
|
223
|
-
- docs/ApiV1TrialsDiscontinuationReasonsGet200ResponseTrialsInner.md
|
|
224
|
-
- docs/ApiV1TrialsEligibilityGeneralizabilityScanGet200Response.md
|
|
225
|
-
- docs/ApiV1TrialsEligibilityGeneralizabilityScanGet200ResponseFilters.md
|
|
226
|
-
- docs/ApiV1TrialsEligibilityGeneralizabilityScanGet200ResponseTrialsInner.md
|
|
227
|
-
- docs/ApiV1TrialsHistoryAndPredictionGet200Response.md
|
|
228
|
-
- docs/ApiV1TrialsHistoryAndPredictionGet200ResponsePredictionsInner.md
|
|
229
|
-
- docs/ApiV1TrialsHistoryAndPredictionGet200ResponsePredictionsInnerBaseline.md
|
|
230
|
-
- docs/ApiV1TrialsHistoryAndPredictionGet200ResponsePredictionsInnerFigure.md
|
|
231
|
-
- docs/ApiV1TrialsHistoryAndPredictionGet200ResponsePredictionsInnerInputsAsRegistered.md
|
|
232
|
-
- docs/ApiV1TrialsHistoryAndPredictionGet200ResponsePredictionsInnerMeasuredError.md
|
|
233
|
-
- docs/ApiV1TrialsHistoryAndPredictionGet200ResponsePredictionsInnerMeasuredErrorPhase.md
|
|
234
|
-
- docs/ApiV1TrialsHistoryAndPredictionGet200ResponsePredictionsInnerMeasuredErrorSize.md
|
|
235
|
-
- docs/ApiV1TrialsHistoryAndPredictionGet200ResponsePredictionsInnerReason.md
|
|
236
|
-
- docs/ApiV1TrialsHistoryAndPredictionGet200ResponsePredictionsStatus.md
|
|
237
|
-
- docs/ApiV1TrialsHistoryAndPredictionGet200ResponseRecordHistory.md
|
|
238
|
-
- docs/ApiV1TrialsHistoryAndPredictionGet200ResponseRecordHistoryChangesInner.md
|
|
239
|
-
- docs/ApiV1TrialsHistoryAndPredictionGet200ResponseRecordHistoryObservationsInner.md
|
|
240
|
-
- docs/ApiV1TrialsHistoryAndPredictionGet200ResponseRecordHistoryObservationsInnerEnrollment.md
|
|
241
|
-
- docs/ApiV1TrialsHistoryAndPredictionGet200ResponseRecordHistoryObservationsInnerSites.md
|
|
242
|
-
- docs/ApiV1TrialsHistoryAndPredictionGet200ResponseRecordHistoryObservationsInnerStartDate.md
|
|
243
|
-
- docs/ApiV1TrialsHistoryAndPredictionGet200ResponseSections.md
|
|
244
|
-
- docs/ApiV1TrialsHistoryPredictionsInnerRegisteredPrimaryCompletion.md
|
|
245
|
-
- docs/ApiV1TrialsHistoryRecordHistoryObservationsInnerOverallStatus.md
|
|
246
|
-
- docs/ApiV1TrialsRecordsGet200Response.md
|
|
247
|
-
- docs/ApiV1TrialsRecordsGet200ResponseBuildState.md
|
|
248
|
-
- docs/ApiV1TrialsRecordsGet200ResponseExtractionCoverage.md
|
|
249
|
-
- docs/ApiV1TrialsRecordsGet200ResponseSections.md
|
|
250
|
-
- docs/ApiV1TrialsRecordsGet200ResponseSectionsExtracted.md
|
|
251
|
-
- docs/ApiV1TrialsRecordsGet200ResponseTrialsInner.md
|
|
252
|
-
- docs/ApiV1TrialsRecordsGet200ResponseTrialsInnerExtracted.md
|
|
253
|
-
- docs/ApiV1TrialsRecordsGet200ResponseTrialsInnerLinkedDrugsInner.md
|
|
254
|
-
- docs/ApiV1TrialsRecordsGet200ResponseTrialsInnerLinkedDrugsInnerBrandsInner.md
|
|
255
|
-
- docs/ApiV1TrialsReportingCompletenessGet200Response.md
|
|
256
|
-
- docs/ApiV1TrialsReportingCompletenessGet200ResponseDemographicFieldPopulationRate.md
|
|
257
91
|
- docs/ApiV1WhoamiGet200Response.md
|
|
258
92
|
- docs/AuthError.md
|
|
93
|
+
- docs/BiomarkersApi.md
|
|
94
|
+
- docs/BiomarkersAssayProviderLedger200Response.md
|
|
95
|
+
- docs/BiomarkersAssayProviderLedger200ResponseAttributionInner.md
|
|
96
|
+
- docs/BiomarkersAssayProviderLedger200ResponsePagination.md
|
|
97
|
+
- docs/BiomarkersAssayProviderLedger200ResponseRowsInner.md
|
|
98
|
+
- docs/BiomarkersCgi200Response.md
|
|
99
|
+
- docs/BiomarkersCgi200ResponseAttributionInner.md
|
|
100
|
+
- docs/BiomarkersCgi200ResponseRowsInner.md
|
|
101
|
+
- docs/BiomarkersCoverageByTraversal200Response.md
|
|
102
|
+
- docs/BiomarkersCoverageByTraversal200ResponseRowsInner.md
|
|
103
|
+
- docs/BiomarkersEvidenceOverTime200Response.md
|
|
104
|
+
- docs/BiomarkersEvidenceOverTime200ResponseContext.md
|
|
105
|
+
- docs/BiomarkersEvidenceOverTime200ResponseRowsInner.md
|
|
106
|
+
- docs/BiomarkersFdaBqp200Response.md
|
|
107
|
+
- docs/BiomarkersFdaBqp200ResponseRowsInner.md
|
|
108
|
+
- docs/BiomarkersFdaCdx200Response.md
|
|
109
|
+
- docs/BiomarkersFdaCdx200ResponseRowsInner.md
|
|
110
|
+
- docs/BiomarkersGet200Response.md
|
|
111
|
+
- docs/BiomarkersGet200ResponseIdentity.md
|
|
112
|
+
- docs/BiomarkersGet200ResponseIdentityRowsInner.md
|
|
113
|
+
- docs/BiomarkersGet200ResponseIdentityRowsInnerValue.md
|
|
114
|
+
- docs/BiomarkersGet200ResponseResolutionConfidence.md
|
|
115
|
+
- docs/BiomarkersGet200ResponseSectionsInner.md
|
|
116
|
+
- docs/BiomarkersHubTierTables200Response.md
|
|
117
|
+
- docs/BiomarkersHubTierTables200ResponseRowsInner.md
|
|
118
|
+
- docs/BiomarkersIdentity200Response.md
|
|
119
|
+
- docs/BiomarkersList200Response.md
|
|
120
|
+
- docs/BiomarkersList200ResponseAttributionInner.md
|
|
121
|
+
- docs/BiomarkersList200ResponseBuildState.md
|
|
122
|
+
- docs/BiomarkersList200ResponseColumnsInner.md
|
|
123
|
+
- docs/BiomarkersList200ResponseFacetsInner.md
|
|
124
|
+
- docs/BiomarkersList200ResponseFacetsInnerOptionsInner.md
|
|
125
|
+
- docs/BiomarkersList200ResponsePagination.md
|
|
126
|
+
- docs/BiomarkersList200ResponseQuery.md
|
|
127
|
+
- docs/BiomarkersList200ResponseQueryFilters.md
|
|
128
|
+
- docs/BiomarkersList200ResponseRowsInner.md
|
|
129
|
+
- docs/BiomarkersList200ResponseShape.md
|
|
130
|
+
- docs/BiomarkersLiterature200Response.md
|
|
131
|
+
- docs/BiomarkersLiterature200ResponseContext.md
|
|
132
|
+
- docs/BiomarkersLiterature200ResponseRowsInner.md
|
|
133
|
+
- docs/BiomarkersOtAssociation200Response.md
|
|
134
|
+
- docs/BiomarkersOtAssociation200ResponseRowsInner.md
|
|
135
|
+
- docs/BiomarkersPopulationAlleleFrequency200Response.md
|
|
136
|
+
- docs/BiomarkersPopulationAlleleFrequency200ResponseAttributionInner.md
|
|
137
|
+
- docs/BiomarkersPopulationAlleleFrequency200ResponseRowsInner.md
|
|
138
|
+
- docs/BiomarkersPublishingOrg200Response.md
|
|
139
|
+
- docs/BiomarkersPublishingOrg200ResponseContext.md
|
|
140
|
+
- docs/BiomarkersPublishingOrg200ResponseRowsInner.md
|
|
141
|
+
- docs/BiomarkersRelatedBiomarkers200Response.md
|
|
142
|
+
- docs/BiomarkersRelatedBiomarkers200ResponseRowsInner.md
|
|
143
|
+
- docs/BiomarkersRelatedConditions200Response.md
|
|
144
|
+
- docs/BiomarkersRelatedOrganizations200Response.md
|
|
145
|
+
- docs/BiomarkersRelations200Response.md
|
|
146
|
+
- docs/BiomarkersRelations200ResponseContext.md
|
|
147
|
+
- docs/BiomarkersRelations200ResponseContextFilters.md
|
|
148
|
+
- docs/BiomarkersRelations200ResponseQuery.md
|
|
149
|
+
- docs/BiomarkersRelations200ResponseRowsInner.md
|
|
150
|
+
- docs/BiomarkersRelations400Response.md
|
|
151
|
+
- docs/BiomarkersSampleScreening200Response.md
|
|
152
|
+
- docs/BiomarkersSampleScreening200ResponseContext.md
|
|
153
|
+
- docs/BiomarkersSampleScreening200ResponseContextCoverageCounts.md
|
|
154
|
+
- docs/BiomarkersSampleScreening200ResponseRowsInner.md
|
|
155
|
+
- docs/BiomarkersSampleScreening200ResponseRowsInnerReferenceScreens.md
|
|
156
|
+
- docs/BiomarkersTrialMention200Response.md
|
|
157
|
+
- docs/BiomarkersTrialMention200ResponseRowsInner.md
|
|
158
|
+
- docs/BiomarkersVariantMentions200Response.md
|
|
159
|
+
- docs/BiomarkersVariantMentions200ResponseRowsInner.md
|
|
160
|
+
- docs/BiomarkersVendorSourcing200Response.md
|
|
161
|
+
- docs/BiomarkersVendorSourcing200ResponseQuery.md
|
|
162
|
+
- docs/BiomarkersVendorSourcing200ResponseRowsInner.md
|
|
163
|
+
- docs/BiomarkersWhereItAppears200Response.md
|
|
164
|
+
- docs/BiomarkersWhereItAppears200ResponseRowsInner.md
|
|
165
|
+
- docs/CellLinesApi.md
|
|
166
|
+
- docs/CellLinesGet200Response.md
|
|
167
|
+
- docs/CellLinesGet200ResponseIdentity.md
|
|
168
|
+
- docs/CellLinesGet200ResponseIdentityRowsInner.md
|
|
169
|
+
- docs/CellLinesIdentity200Response.md
|
|
170
|
+
- docs/CellLinesList200Response.md
|
|
171
|
+
- docs/CellLinesList200ResponseAttributionInner.md
|
|
172
|
+
- docs/CellLinesList200ResponseQuery.md
|
|
173
|
+
- docs/CellLinesList200ResponseQueryFilters.md
|
|
174
|
+
- docs/CellLinesList200ResponseRowsInner.md
|
|
175
|
+
- docs/CellLinesSafetyResolution200Response.md
|
|
176
|
+
- docs/CellLinesSafetyResolution200ResponseRowsInner.md
|
|
177
|
+
- docs/CellLinesSafetyResolution200ResponseRowsInnerValue.md
|
|
178
|
+
- docs/CellLinesStatusCounts200Response.md
|
|
179
|
+
- docs/CellLinesStatusCounts200ResponseRowsInner.md
|
|
259
180
|
- docs/NotEntitledError.md
|
|
181
|
+
- docs/OrgsActivePrograms200Response.md
|
|
182
|
+
- docs/OrgsActivitySummary200Response.md
|
|
183
|
+
- docs/OrgsActivitySummary200ResponseRowsInner.md
|
|
184
|
+
- docs/OrgsApi.md
|
|
185
|
+
- docs/OrgsApprovedAssets200Response.md
|
|
186
|
+
- docs/OrgsApprovedAssets200ResponseContext.md
|
|
187
|
+
- docs/OrgsApprovedAssets200ResponseRowsInner.md
|
|
188
|
+
- docs/OrgsBenzingaCatalysts200Response.md
|
|
189
|
+
- docs/OrgsBenzingaCatalysts200ResponseAttributionInner.md
|
|
190
|
+
- docs/OrgsBenzingaCatalysts200ResponseRestriction.md
|
|
191
|
+
- docs/OrgsBiomarkerCapability200Response.md
|
|
192
|
+
- docs/OrgsClia200Response.md
|
|
193
|
+
- docs/OrgsClimate200Response.md
|
|
194
|
+
- docs/OrgsClimate200ResponseRowsInner.md
|
|
195
|
+
- docs/OrgsCollaborators200Response.md
|
|
196
|
+
- docs/OrgsCollaborators200ResponseRowsInner.md
|
|
197
|
+
- docs/OrgsCompany200Response.md
|
|
198
|
+
- docs/OrgsCompany200ResponseRowsInner.md
|
|
199
|
+
- docs/OrgsCompetitors200Response.md
|
|
200
|
+
- docs/OrgsCompetitors200ResponseRowsInner.md
|
|
201
|
+
- docs/OrgsCoverage200Response.md
|
|
202
|
+
- docs/OrgsCoverage200ResponseRowsInner.md
|
|
203
|
+
- docs/OrgsCoverage200ResponseRowsInnerValue.md
|
|
204
|
+
- docs/OrgsCurrentOwnership200Response.md
|
|
205
|
+
- docs/OrgsCurrentOwnership200ResponseAttributionInner.md
|
|
206
|
+
- docs/OrgsCurrentOwnership200ResponseContext.md
|
|
207
|
+
- docs/OrgsCurrentOwnership200ResponseContextTotals.md
|
|
208
|
+
- docs/OrgsCurrentOwnership200ResponseRowsInner.md
|
|
209
|
+
- docs/OrgsDeclarations200Response.md
|
|
210
|
+
- docs/OrgsDeclarations200ResponseRowsInner.md
|
|
211
|
+
- docs/OrgsDelivery200Response.md
|
|
212
|
+
- docs/OrgsDelivery200ResponseRowsInner.md
|
|
213
|
+
- docs/OrgsDescription200Response.md
|
|
214
|
+
- docs/OrgsDescription200ResponseRowsInner.md
|
|
215
|
+
- docs/OrgsDiseaseAreas200Response.md
|
|
216
|
+
- docs/OrgsDiseaseAreas200ResponseRowsInner.md
|
|
217
|
+
- docs/OrgsDiversity200Response.md
|
|
218
|
+
- docs/OrgsDiversity200ResponseRowsInner.md
|
|
219
|
+
- docs/OrgsEsgTrend200Response.md
|
|
220
|
+
- docs/OrgsEsgTrend200ResponseAttributionInner.md
|
|
221
|
+
- docs/OrgsEsgTrend200ResponseContext.md
|
|
222
|
+
- docs/OrgsEsgTrend200ResponseRowsInner.md
|
|
223
|
+
- docs/OrgsFinancialLineItems200Response.md
|
|
224
|
+
- docs/OrgsFinancialLineItems200ResponseContext.md
|
|
225
|
+
- docs/OrgsFinancialLineItems200ResponseContextGroupsInner.md
|
|
226
|
+
- docs/OrgsFinancialLineItems200ResponseRowsInner.md
|
|
227
|
+
- docs/OrgsFinancialOverview200Response.md
|
|
228
|
+
- docs/OrgsFinancialOverview200ResponseContext.md
|
|
229
|
+
- docs/OrgsFinancialOverview200ResponseRowsInner.md
|
|
230
|
+
- docs/OrgsFinancialOverview200ResponseRowsInnerValue.md
|
|
231
|
+
- docs/OrgsFinancials200Response.md
|
|
232
|
+
- docs/OrgsFinancials200ResponseRowsInner.md
|
|
233
|
+
- docs/OrgsFunding200Response.md
|
|
234
|
+
- docs/OrgsFunding200ResponseContext.md
|
|
235
|
+
- docs/OrgsFunding200ResponseContextSummary.md
|
|
236
|
+
- docs/OrgsFunding200ResponseRowsInner.md
|
|
237
|
+
- docs/OrgsGet200Response.md
|
|
238
|
+
- docs/OrgsGet200ResponseIdentity.md
|
|
239
|
+
- docs/OrgsGet200ResponseIdentityRowsInner.md
|
|
240
|
+
- docs/OrgsGet200ResponseIdentityRowsInnerValue.md
|
|
241
|
+
- docs/OrgsGet200ResponseSectionsInner.md
|
|
242
|
+
- docs/OrgsGroupSections200Response.md
|
|
243
|
+
- docs/OrgsGroupSections200ResponseContext.md
|
|
244
|
+
- docs/OrgsGroupSections200ResponseRowsInner.md
|
|
245
|
+
- docs/OrgsGroupStructure200Response.md
|
|
246
|
+
- docs/OrgsGroupStructure200ResponseContext.md
|
|
247
|
+
- docs/OrgsGroupStructure200ResponseRowsInner.md
|
|
248
|
+
- docs/OrgsGxpSites200Response.md
|
|
249
|
+
- docs/OrgsGxpSites200ResponseContext.md
|
|
250
|
+
- docs/OrgsGxpSites200ResponseContextGroupCompaniesInner.md
|
|
251
|
+
- docs/OrgsGxpSites200ResponseRowsInner.md
|
|
252
|
+
- docs/OrgsGxpSitesMap200Response.md
|
|
253
|
+
- docs/OrgsIdentity200Response.md
|
|
254
|
+
- docs/OrgsImportRefusals200Response.md
|
|
255
|
+
- docs/OrgsInstitutional13f200Response.md
|
|
256
|
+
- docs/OrgsInstitutional13f200ResponseContext.md
|
|
257
|
+
- docs/OrgsInstitutional13f200ResponseRowsInner.md
|
|
258
|
+
- docs/OrgsJournals200Response.md
|
|
259
|
+
- docs/OrgsList200Response.md
|
|
260
|
+
- docs/OrgsList200ResponsePagination.md
|
|
261
|
+
- docs/OrgsList200ResponseQuery.md
|
|
262
|
+
- docs/OrgsList200ResponseRowsInner.md
|
|
263
|
+
- docs/OrgsMemberChildren200Response.md
|
|
264
|
+
- docs/OrgsMemberIdentity200Response.md
|
|
265
|
+
- docs/OrgsMemberIdentity200ResponseContext.md
|
|
266
|
+
- docs/OrgsMemberIdentity200ResponseContextIdentifiersInner.md
|
|
267
|
+
- docs/OrgsMemberIdentity200ResponseContextParent.md
|
|
268
|
+
- docs/OrgsMemberIdentity200ResponseRowsInner.md
|
|
269
|
+
- docs/OrgsMemberRecords200Response.md
|
|
270
|
+
- docs/OrgsMemberRecords200ResponseContext.md
|
|
271
|
+
- docs/OrgsMemberRecords200ResponseRowsInner.md
|
|
272
|
+
- docs/OrgsMembers200Response.md
|
|
273
|
+
- docs/OrgsMembers200ResponseRowsInner.md
|
|
274
|
+
- docs/OrgsOrgAssets200Response.md
|
|
275
|
+
- docs/OrgsOrgAssets200ResponseRowsInner.md
|
|
276
|
+
- docs/OrgsOrgCustomer200Response.md
|
|
277
|
+
- docs/OrgsOrgCustomer200ResponseRowsInner.md
|
|
278
|
+
- docs/OrgsOrgGleif200Response.md
|
|
279
|
+
- docs/OrgsOrgGleif200ResponseRowsInner.md
|
|
280
|
+
- docs/OrgsOrgHosted200Response.md
|
|
281
|
+
- docs/OrgsOrgHosted200ResponseRowsInner.md
|
|
282
|
+
- docs/OrgsOrgOwnedDrugs200Response.md
|
|
283
|
+
- docs/OrgsOrgOwnedDrugs200ResponseRowsInner.md
|
|
284
|
+
- docs/OrgsOrgOwnership200Response.md
|
|
285
|
+
- docs/OrgsOrgOwnership200ResponseContext.md
|
|
286
|
+
- docs/OrgsOrgOwnership200ResponseContextTruncated.md
|
|
287
|
+
- docs/OrgsOrgPatentMentions200Response.md
|
|
288
|
+
- docs/OrgsOrgPatentMentions200ResponseAttributionInner.md
|
|
289
|
+
- docs/OrgsOrgPatentMentions200ResponseRowsInner.md
|
|
290
|
+
- docs/OrgsOrgPeople200Response.md
|
|
291
|
+
- docs/OrgsOrgPeople200ResponseContext.md
|
|
292
|
+
- docs/OrgsOrgPeople200ResponseRowsInner.md
|
|
293
|
+
- docs/OrgsOrgPipeline200Response.md
|
|
294
|
+
- docs/OrgsOrgPipeline200ResponseContext.md
|
|
295
|
+
- docs/OrgsOrgPipeline200ResponseContextCounts.md
|
|
296
|
+
- docs/OrgsOrgPipeline200ResponseRowsInner.md
|
|
297
|
+
- docs/OrgsOrgPrograms200Response.md
|
|
298
|
+
- docs/OrgsOrgPrograms200ResponseContext.md
|
|
299
|
+
- docs/OrgsOrgPrograms200ResponseRowsInner.md
|
|
300
|
+
- docs/OrgsOrgPublications200Response.md
|
|
301
|
+
- docs/OrgsOrgPublications200ResponseRowsInner.md
|
|
302
|
+
- docs/OrgsOrgRecruitment200Response.md
|
|
303
|
+
- docs/OrgsOrgRecruitment200ResponseContext.md
|
|
304
|
+
- docs/OrgsOrgRecruitment200ResponseContextPredicted.md
|
|
305
|
+
- docs/OrgsOrgRecruitment200ResponseContextRealized.md
|
|
306
|
+
- docs/OrgsOrgRecruitment200ResponseContextStatuses.md
|
|
307
|
+
- docs/OrgsOrgRelationships200Response.md
|
|
308
|
+
- docs/OrgsOrgRelationships200ResponseQuery.md
|
|
309
|
+
- docs/OrgsOrgSupplier200Response.md
|
|
310
|
+
- docs/OrgsOrgSupplier200ResponseRowsInner.md
|
|
311
|
+
- docs/OrgsOrgTargets200Response.md
|
|
312
|
+
- docs/OrgsOrgTargets200ResponseRowsInner.md
|
|
313
|
+
- docs/OrgsOrgTypeTally200Response.md
|
|
314
|
+
- docs/OrgsOrgTypeTally200ResponseContext.md
|
|
315
|
+
- docs/OrgsOrgTypeTally200ResponseRowsInner.md
|
|
316
|
+
- docs/OrgsOrgUsPatents200Response.md
|
|
317
|
+
- docs/OrgsOrgUsPatents200ResponseContext.md
|
|
318
|
+
- docs/OrgsOrgUsPatents200ResponseRowsInner.md
|
|
319
|
+
- docs/OrgsOverviewDigest200Response.md
|
|
320
|
+
- docs/OrgsOverviewDigest200ResponseRowsInner.md
|
|
321
|
+
- docs/OrgsOwnershipCoverage200Response.md
|
|
322
|
+
- docs/OrgsOwnershipCoverage200ResponseRowsInner.md
|
|
323
|
+
- docs/OrgsOwnershipHistory200Response.md
|
|
324
|
+
- docs/OrgsOwnershipHistory200ResponseContext.md
|
|
325
|
+
- docs/OrgsOwnershipHistory200ResponseRowsInner.md
|
|
326
|
+
- docs/OrgsOwnershipPercentages200Response.md
|
|
327
|
+
- docs/OrgsOwnershipPercentages200ResponseContext.md
|
|
328
|
+
- docs/OrgsOwnershipPercentages200ResponseContextInsider.md
|
|
329
|
+
- docs/OrgsOwnershipPercentages200ResponseContextInstitutional.md
|
|
330
|
+
- docs/OrgsOwnershipPercentages200ResponseContextSharesOutstanding.md
|
|
331
|
+
- docs/OrgsOwnershipPercentages200ResponseRowsInner.md
|
|
332
|
+
- docs/OrgsOwnershipPercentages200ResponseRowsInnerAsOf.md
|
|
333
|
+
- docs/OrgsPatentCliff200Response.md
|
|
334
|
+
- docs/OrgsPatentCliff200ResponseContext.md
|
|
335
|
+
- docs/OrgsPatentCliff200ResponseRowsInner.md
|
|
336
|
+
- docs/OrgsPatentVsTrial200Response.md
|
|
337
|
+
- docs/OrgsPatentVsTrial200ResponseContext.md
|
|
338
|
+
- docs/OrgsPatentVsTrial200ResponseContextPortfolio.md
|
|
339
|
+
- docs/OrgsPatentVsTrial200ResponseRowsInner.md
|
|
340
|
+
- docs/OrgsPatents200Response.md
|
|
341
|
+
- docs/OrgsPatents200ResponseContext.md
|
|
342
|
+
- docs/OrgsPatents200ResponseRowsInner.md
|
|
343
|
+
- docs/OrgsPdufaReconciliation200Response.md
|
|
344
|
+
- docs/OrgsPdufaReconciliation200ResponseContext.md
|
|
345
|
+
- docs/OrgsPdufaReconciliation200ResponseContextStatusCounts.md
|
|
346
|
+
- docs/OrgsPdufaReconciliation200ResponseRowsInner.md
|
|
347
|
+
- docs/OrgsPeers200Response.md
|
|
348
|
+
- docs/OrgsPeers200ResponseRowsInner.md
|
|
349
|
+
- docs/OrgsPhaseStatus200Response.md
|
|
350
|
+
- docs/OrgsPhaseStatus200ResponseContext.md
|
|
351
|
+
- docs/OrgsPhaseStatus200ResponseRowsInner.md
|
|
352
|
+
- docs/OrgsPublishingBiomarkers200Response.md
|
|
353
|
+
- docs/OrgsPublishingBiomarkers200ResponseContext.md
|
|
354
|
+
- docs/OrgsPublishingBiomarkers200ResponseContextCoverage.md
|
|
355
|
+
- docs/OrgsRareActivity200Response.md
|
|
356
|
+
- docs/OrgsRareActivity200ResponseContext.md
|
|
357
|
+
- docs/OrgsRareActivity200ResponseRowsInner.md
|
|
358
|
+
- docs/OrgsRegistryShell200Response.md
|
|
359
|
+
- docs/OrgsRegistryShell200ResponseRowsInner.md
|
|
360
|
+
- docs/OrgsRelatedConditions200Response.md
|
|
361
|
+
- docs/OrgsRelatedConditions200ResponseRowsInner.md
|
|
362
|
+
- docs/OrgsRelatedUnfolded200Response.md
|
|
363
|
+
- docs/OrgsRelatedUnfolded200ResponseRowsInner.md
|
|
364
|
+
- docs/OrgsRevenueByDrug200Response.md
|
|
365
|
+
- docs/OrgsRevenueByDrug200ResponseContext.md
|
|
366
|
+
- docs/OrgsRevenueByDrug200ResponseRowsInner.md
|
|
367
|
+
- docs/OrgsRevenueGeography200Response.md
|
|
368
|
+
- docs/OrgsRevenueGeography200ResponseContext.md
|
|
369
|
+
- docs/OrgsRevenueGeography200ResponseRowsInner.md
|
|
370
|
+
- docs/OrgsSameNameSecFiler200Response.md
|
|
371
|
+
- docs/OrgsSameNameSecFiler200ResponseRowsInner.md
|
|
372
|
+
- docs/OrgsSbtiCrosscheck200Response.md
|
|
373
|
+
- docs/OrgsSbtiCrosscheck200ResponseRowsInner.md
|
|
374
|
+
- docs/OrgsScientistCom200Response.md
|
|
375
|
+
- docs/OrgsScientistCom200ResponseContext.md
|
|
376
|
+
- docs/OrgsScientistCom200ResponseRowsInner.md
|
|
377
|
+
- docs/OrgsSecFilerShell200Response.md
|
|
378
|
+
- docs/OrgsSecFilerShell200ResponseRowsInner.md
|
|
379
|
+
- docs/OrgsSecFilerShell200ResponseRowsInnerValue.md
|
|
380
|
+
- docs/OrgsSecFilerShell200ResponseRowsInnerValueOneOf.md
|
|
381
|
+
- docs/OrgsSecPdufa200Response.md
|
|
382
|
+
- docs/OrgsSecPdufa200ResponseRowsInner.md
|
|
383
|
+
- docs/OrgsSupplierLinks200Response.md
|
|
384
|
+
- docs/OrgsTimeline200Response.md
|
|
385
|
+
- docs/OrgsTimeline200ResponseRowsInner.md
|
|
386
|
+
- docs/OrgsTopConditions200Response.md
|
|
387
|
+
- docs/OrgsTopConditions200ResponseRowsInner.md
|
|
388
|
+
- docs/OrgsTopDrugs200Response.md
|
|
389
|
+
- docs/OrgsTopDrugs200ResponseRowsInner.md
|
|
390
|
+
- docs/OrgsTrialsPerYear200Response.md
|
|
391
|
+
- docs/OrgsUnmatchedRevenue200Response.md
|
|
392
|
+
- docs/OrgsUnmatchedRevenue200ResponseRowsInner.md
|
|
393
|
+
- docs/OrgsUnmatchedRevenue200ResponseRowsInnerValue.md
|
|
260
394
|
- lib/pharmaobservatory.rb
|
|
261
395
|
- lib/pharmaobservatory/api/api_v1_base_api.rb
|
|
262
|
-
- lib/pharmaobservatory/api/
|
|
263
|
-
- lib/pharmaobservatory/api/
|
|
264
|
-
- lib/pharmaobservatory/api/
|
|
265
|
-
- lib/pharmaobservatory/api/api_v1_condition_api.rb
|
|
266
|
-
- lib/pharmaobservatory/api/api_v1_enrollment_benchmark_api.rb
|
|
267
|
-
- lib/pharmaobservatory/api/api_v1_ownership_api.rb
|
|
268
|
-
- lib/pharmaobservatory/api/api_v1_program_catalyst_api.rb
|
|
269
|
-
- lib/pharmaobservatory/api/api_v1_resolve_entity_api.rb
|
|
270
|
-
- lib/pharmaobservatory/api/api_v1_rwd_api.rb
|
|
271
|
-
- lib/pharmaobservatory/api/api_v1_site_record_api.rb
|
|
272
|
-
- lib/pharmaobservatory/api/api_v1_trial_api.rb
|
|
396
|
+
- lib/pharmaobservatory/api/biomarkers_api.rb
|
|
397
|
+
- lib/pharmaobservatory/api/cell_lines_api.rb
|
|
398
|
+
- lib/pharmaobservatory/api/orgs_api.rb
|
|
273
399
|
- lib/pharmaobservatory/api_client.rb
|
|
274
400
|
- lib/pharmaobservatory/api_error.rb
|
|
275
401
|
- lib/pharmaobservatory/configuration.rb
|
|
276
|
-
- lib/pharmaobservatory/models/api_v1_biomarker_assay_screen_get200_response.rb
|
|
277
|
-
- lib/pharmaobservatory/models/api_v1_biomarker_assay_screen_get200_response_build_state.rb
|
|
278
|
-
- lib/pharmaobservatory/models/api_v1_biomarker_assay_screen_get200_response_evidence_inner.rb
|
|
279
|
-
- lib/pharmaobservatory/models/api_v1_biomarker_assay_screen_get200_response_evidence_inner_source_ref.rb
|
|
280
|
-
- lib/pharmaobservatory/models/api_v1_biomarker_assay_screen_get200_response_filters.rb
|
|
281
|
-
- lib/pharmaobservatory/models/api_v1_biomarker_assay_whitespace_get200_response.rb
|
|
282
|
-
- lib/pharmaobservatory/models/api_v1_biomarker_assay_whitespace_get200_response_bucket_counts.rb
|
|
283
|
-
- lib/pharmaobservatory/models/api_v1_biomarker_assay_whitespace_get200_response_filters.rb
|
|
284
|
-
- lib/pharmaobservatory/models/api_v1_biomarker_assay_whitespace_get200_response_genes_inner.rb
|
|
285
|
-
- lib/pharmaobservatory/models/api_v1_biomarker_assay_whitespace_get200_response_literature_evidence_inner.rb
|
|
286
|
-
- lib/pharmaobservatory/models/api_v1_biomarker_assay_whitespace_get200_response_profile_link.rb
|
|
287
|
-
- lib/pharmaobservatory/models/api_v1_biomarker_assay_whitespace_get200_response_supplier_declarations_inner.rb
|
|
288
|
-
- lib/pharmaobservatory/models/api_v1_biomarker_assay_whitespace_get200_response_validated_evidence_inner.rb
|
|
289
|
-
- lib/pharmaobservatory/models/api_v1_candidate_sites_get200_response.rb
|
|
290
|
-
- lib/pharmaobservatory/models/api_v1_candidate_sites_get200_response_filters.rb
|
|
291
|
-
- lib/pharmaobservatory/models/api_v1_candidate_sites_get200_response_sites_inner.rb
|
|
292
|
-
- lib/pharmaobservatory/models/api_v1_conditions_condition_id_burden_vs_evidence_get200_response.rb
|
|
293
|
-
- lib/pharmaobservatory/models/api_v1_conditions_condition_id_burden_vs_evidence_get200_response_restriction.rb
|
|
294
|
-
- lib/pharmaobservatory/models/api_v1_conditions_condition_id_evidence_freshness_get200_response.rb
|
|
295
|
-
- lib/pharmaobservatory/models/api_v1_conditions_condition_id_evidence_freshness_get200_response_build_state.rb
|
|
296
|
-
- lib/pharmaobservatory/models/api_v1_conditions_condition_id_evidence_freshness_get200_response_sections.rb
|
|
297
|
-
- lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response.rb
|
|
298
|
-
- lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_active_year_span.rb
|
|
299
|
-
- lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_phase_breakdown_inner.rb
|
|
300
|
-
- lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_recruitment_rollup.rb
|
|
301
|
-
- lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_recruitment_rollup_figures_inner.rb
|
|
302
|
-
- lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_recruitment_rollup_phases_inner.rb
|
|
303
|
-
- lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_recruitment_rollup_predicted.rb
|
|
304
|
-
- lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_recruitment_rollup_realized.rb
|
|
305
|
-
- lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_recruitment_rollup_statuses.rb
|
|
306
|
-
- lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_sections.rb
|
|
307
|
-
- lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_sponsors_inner.rb
|
|
308
|
-
- lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_trial_start_forecast.rb
|
|
309
|
-
- lib/pharmaobservatory/models/api_v1_conditions_condition_id_sponsor_landscape_get200_response_trials_by_year_inner.rb
|
|
310
|
-
- lib/pharmaobservatory/models/api_v1_enrollment_benchmark_get200_response.rb
|
|
311
|
-
- lib/pharmaobservatory/models/api_v1_enrollment_benchmark_get200_response_benchmark.rb
|
|
312
|
-
- lib/pharmaobservatory/models/api_v1_enrollment_benchmark_get200_response_benchmark_accrual_rate_per_site_month.rb
|
|
313
|
-
- lib/pharmaobservatory/models/api_v1_enrollment_benchmark_get200_response_benchmark_confidence.rb
|
|
314
|
-
- lib/pharmaobservatory/models/api_v1_enrollment_benchmark_get200_response_benchmark_enrollment.rb
|
|
315
|
-
- lib/pharmaobservatory/models/api_v1_enrollment_benchmark_get200_response_benchmark_typical_duration_months.rb
|
|
316
|
-
- lib/pharmaobservatory/models/api_v1_enrollment_benchmark_get200_response_filters.rb
|
|
317
|
-
- lib/pharmaobservatory/models/api_v1_investor_profile_get200_response.rb
|
|
318
|
-
- lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_funds.rb
|
|
319
|
-
- lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_funds_rollup_inner.rb
|
|
320
|
-
- lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_ownership.rb
|
|
321
|
-
- lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_ownership_holdings.rb
|
|
322
|
-
- lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_ownership_owners.rb
|
|
323
|
-
- lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_ownership_owners_rows_inner.rb
|
|
324
|
-
- lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_profile.rb
|
|
325
|
-
- lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_resolution.rb
|
|
326
|
-
- lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_sections.rb
|
|
327
|
-
- lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_semantics.rb
|
|
328
|
-
- lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_semantics_ownership_dimension.rb
|
|
329
|
-
- lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_semantics_source_class.rb
|
|
330
|
-
- lib/pharmaobservatory/models/api_v1_investor_profile_get200_response_semantics_source_class_sec_form_adv.rb
|
|
331
|
-
- lib/pharmaobservatory/models/api_v1_licensing_candidates_get200_response.rb
|
|
332
|
-
- lib/pharmaobservatory/models/api_v1_licensing_candidates_get200_response_candidates_inner.rb
|
|
333
|
-
- lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response.rb
|
|
334
|
-
- lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_financing.rb
|
|
335
|
-
- lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_financing_rounds_inner.rb
|
|
336
|
-
- lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_financing_summary.rb
|
|
337
|
-
- lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_investors.rb
|
|
338
|
-
- lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_ownership_percentages.rb
|
|
339
|
-
- lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_ownership_percentages_insider.rb
|
|
340
|
-
- lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_ownership_percentages_institutional.rb
|
|
341
|
-
- lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_ownership_percentages_notes.rb
|
|
342
|
-
- lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_ownership_percentages_shares_outstanding.rb
|
|
343
|
-
- lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_ownership_positions.rb
|
|
344
|
-
- lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_ownership_positions_institutional13f.rb
|
|
345
|
-
- lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_ownership_positions_positions_inner.rb
|
|
346
|
-
- lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_sections.rb
|
|
347
|
-
- lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_semantics.rb
|
|
348
|
-
- lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_semantics_ownership_dimension.rb
|
|
349
|
-
- lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_semantics_source_class.rb
|
|
350
|
-
- lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_get200_response_unmatched_product_revenue.rb
|
|
351
|
-
- lib/pharmaobservatory/models/api_v1_org_financing_and_ownership_ownership_positions_institutional13f_holders_inner.rb
|
|
352
|
-
- lib/pharmaobservatory/models/api_v1_org_pipeline_stages_get200_response.rb
|
|
353
|
-
- lib/pharmaobservatory/models/api_v1_org_pipeline_stages_get200_response_approved_marketed_inner.rb
|
|
354
|
-
- lib/pharmaobservatory/models/api_v1_org_pipeline_stages_get200_response_in_development_inner.rb
|
|
355
|
-
- lib/pharmaobservatory/models/api_v1_org_pipeline_stages_get200_response_recruitment_rollup.rb
|
|
356
|
-
- lib/pharmaobservatory/models/api_v1_org_pipeline_stages_get200_response_recruitment_rollup_phases_inner.rb
|
|
357
|
-
- lib/pharmaobservatory/models/api_v1_org_pipeline_stages_get200_response_recruitment_rollup_predicted.rb
|
|
358
|
-
- lib/pharmaobservatory/models/api_v1_org_pipeline_stages_get200_response_sections.rb
|
|
359
|
-
- lib/pharmaobservatory/models/api_v1_org_pipeline_stages_get200_response_trial_start_forecast.rb
|
|
360
|
-
- lib/pharmaobservatory/models/api_v1_org_pipeline_stages_get200_response_trial_start_forecast_years_inner.rb
|
|
361
|
-
- lib/pharmaobservatory/models/api_v1_patent_cliff_exposure_get200_response.rb
|
|
362
|
-
- lib/pharmaobservatory/models/api_v1_patent_cliff_exposure_get200_response_exposures_inner.rb
|
|
363
|
-
- lib/pharmaobservatory/models/api_v1_program_catalysts_get200_response.rb
|
|
364
|
-
- lib/pharmaobservatory/models/api_v1_program_catalysts_get200_response_calendar_inner.rb
|
|
365
|
-
- lib/pharmaobservatory/models/api_v1_program_catalysts_get200_response_pdufa.rb
|
|
366
|
-
- lib/pharmaobservatory/models/api_v1_program_catalysts_get200_response_sections.rb
|
|
367
|
-
- lib/pharmaobservatory/models/api_v1_resolve_entity_get200_response.rb
|
|
368
|
-
- lib/pharmaobservatory/models/api_v1_resolve_entity_get200_response_candidates_inner.rb
|
|
369
|
-
- lib/pharmaobservatory/models/api_v1_resolve_entity_get200_response_candidates_inner_restriction.rb
|
|
370
|
-
- lib/pharmaobservatory/models/api_v1_resolve_entity_get200_response_resolution_confidence.rb
|
|
371
|
-
- lib/pharmaobservatory/models/api_v1_rwd_conductor_track_record_get200_response.rb
|
|
372
|
-
- lib/pharmaobservatory/models/api_v1_rwd_conductor_track_record_get200_response_conductor.rb
|
|
373
|
-
- lib/pharmaobservatory/models/api_v1_rwd_conductor_track_record_get200_response_delivery_by_mandate.rb
|
|
374
|
-
- lib/pharmaobservatory/models/api_v1_rwd_conductor_track_record_get200_response_delivery_by_mandate_all.rb
|
|
375
|
-
- lib/pharmaobservatory/models/api_v1_rwd_conductor_track_record_get200_response_delivery_by_mandate_mandated.rb
|
|
376
|
-
- lib/pharmaobservatory/models/api_v1_rwd_conductor_track_record_get200_response_delivery_by_mandate_voluntary.rb
|
|
377
|
-
- lib/pharmaobservatory/models/api_v1_rwd_conductor_track_record_get200_response_footprint.rb
|
|
378
|
-
- lib/pharmaobservatory/models/api_v1_rwd_conductor_track_record_get200_response_footprint_delivered_countries_inner.rb
|
|
379
|
-
- lib/pharmaobservatory/models/api_v1_rwd_study_screen_get200_response.rb
|
|
380
|
-
- lib/pharmaobservatory/models/api_v1_rwd_study_screen_get200_response_delivery_distribution.rb
|
|
381
|
-
- lib/pharmaobservatory/models/api_v1_rwd_study_screen_get200_response_filters.rb
|
|
382
|
-
- lib/pharmaobservatory/models/api_v1_site_record_get200_response.rb
|
|
383
|
-
- lib/pharmaobservatory/models/api_v1_site_record_get200_response_detail_sections.rb
|
|
384
|
-
- lib/pharmaobservatory/models/api_v1_site_record_get200_response_detail_sections_trials.rb
|
|
385
|
-
- lib/pharmaobservatory/models/api_v1_site_record_get200_response_site_key_redirect.rb
|
|
386
|
-
- lib/pharmaobservatory/models/api_v1_site_record_get200_response_sites_inner.rb
|
|
387
|
-
- lib/pharmaobservatory/models/api_v1_site_record_get200_response_sites_inner_active_years.rb
|
|
388
|
-
- lib/pharmaobservatory/models/api_v1_site_record_get200_response_sites_inner_drugs_inner.rb
|
|
389
|
-
- lib/pharmaobservatory/models/api_v1_site_record_get200_response_sites_inner_estimated_enrollment.rb
|
|
390
|
-
- lib/pharmaobservatory/models/api_v1_site_record_get200_response_sites_inner_indications_inner.rb
|
|
391
|
-
- lib/pharmaobservatory/models/api_v1_site_record_get200_response_sites_inner_investigators_inner.rb
|
|
392
|
-
- lib/pharmaobservatory/models/api_v1_site_record_get200_response_sites_inner_trials_inner.rb
|
|
393
|
-
- lib/pharmaobservatory/models/api_v1_sponsor_landscape_recruitment_rollup_predicted_at_horizon_cap.rb
|
|
394
|
-
- lib/pharmaobservatory/models/api_v1_sponsor_landscape_recruitment_rollup_status_counts_inner.rb
|
|
395
|
-
- lib/pharmaobservatory/models/api_v1_trials_discontinuation_reasons_get200_response.rb
|
|
396
|
-
- lib/pharmaobservatory/models/api_v1_trials_discontinuation_reasons_get200_response_filters.rb
|
|
397
|
-
- lib/pharmaobservatory/models/api_v1_trials_discontinuation_reasons_get200_response_trials_inner.rb
|
|
398
|
-
- lib/pharmaobservatory/models/api_v1_trials_eligibility_generalizability_scan_get200_response.rb
|
|
399
|
-
- lib/pharmaobservatory/models/api_v1_trials_eligibility_generalizability_scan_get200_response_filters.rb
|
|
400
|
-
- lib/pharmaobservatory/models/api_v1_trials_eligibility_generalizability_scan_get200_response_trials_inner.rb
|
|
401
|
-
- lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response.rb
|
|
402
|
-
- lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_predictions_inner.rb
|
|
403
|
-
- lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_predictions_inner_baseline.rb
|
|
404
|
-
- lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_predictions_inner_figure.rb
|
|
405
|
-
- lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_predictions_inner_inputs_as_registered.rb
|
|
406
|
-
- lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_predictions_inner_measured_error.rb
|
|
407
|
-
- lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_predictions_inner_measured_error_phase.rb
|
|
408
|
-
- lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_predictions_inner_measured_error_size.rb
|
|
409
|
-
- lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_predictions_inner_reason.rb
|
|
410
|
-
- lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_predictions_status.rb
|
|
411
|
-
- lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_record_history.rb
|
|
412
|
-
- lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_record_history_changes_inner.rb
|
|
413
|
-
- lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_record_history_observations_inner.rb
|
|
414
|
-
- lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_record_history_observations_inner_enrollment.rb
|
|
415
|
-
- lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_record_history_observations_inner_sites.rb
|
|
416
|
-
- lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_record_history_observations_inner_start_date.rb
|
|
417
|
-
- lib/pharmaobservatory/models/api_v1_trials_history_and_prediction_get200_response_sections.rb
|
|
418
|
-
- lib/pharmaobservatory/models/api_v1_trials_history_predictions_inner_registered_primary_completion.rb
|
|
419
|
-
- lib/pharmaobservatory/models/api_v1_trials_history_record_history_observations_inner_overall_status.rb
|
|
420
|
-
- lib/pharmaobservatory/models/api_v1_trials_records_get200_response.rb
|
|
421
|
-
- lib/pharmaobservatory/models/api_v1_trials_records_get200_response_build_state.rb
|
|
422
|
-
- lib/pharmaobservatory/models/api_v1_trials_records_get200_response_extraction_coverage.rb
|
|
423
|
-
- lib/pharmaobservatory/models/api_v1_trials_records_get200_response_sections.rb
|
|
424
|
-
- lib/pharmaobservatory/models/api_v1_trials_records_get200_response_sections_extracted.rb
|
|
425
|
-
- lib/pharmaobservatory/models/api_v1_trials_records_get200_response_trials_inner.rb
|
|
426
|
-
- lib/pharmaobservatory/models/api_v1_trials_records_get200_response_trials_inner_extracted.rb
|
|
427
|
-
- lib/pharmaobservatory/models/api_v1_trials_records_get200_response_trials_inner_linked_drugs_inner.rb
|
|
428
|
-
- lib/pharmaobservatory/models/api_v1_trials_records_get200_response_trials_inner_linked_drugs_inner_brands_inner.rb
|
|
429
|
-
- lib/pharmaobservatory/models/api_v1_trials_reporting_completeness_get200_response.rb
|
|
430
|
-
- lib/pharmaobservatory/models/api_v1_trials_reporting_completeness_get200_response_demographic_field_population_rate.rb
|
|
431
402
|
- lib/pharmaobservatory/models/api_v1_whoami_get200_response.rb
|
|
432
403
|
- lib/pharmaobservatory/models/auth_error.rb
|
|
404
|
+
- lib/pharmaobservatory/models/biomarkers_assay_provider_ledger200_response.rb
|
|
405
|
+
- lib/pharmaobservatory/models/biomarkers_assay_provider_ledger200_response_attribution_inner.rb
|
|
406
|
+
- lib/pharmaobservatory/models/biomarkers_assay_provider_ledger200_response_pagination.rb
|
|
407
|
+
- lib/pharmaobservatory/models/biomarkers_assay_provider_ledger200_response_rows_inner.rb
|
|
408
|
+
- lib/pharmaobservatory/models/biomarkers_cgi200_response.rb
|
|
409
|
+
- lib/pharmaobservatory/models/biomarkers_cgi200_response_attribution_inner.rb
|
|
410
|
+
- lib/pharmaobservatory/models/biomarkers_cgi200_response_rows_inner.rb
|
|
411
|
+
- lib/pharmaobservatory/models/biomarkers_coverage_by_traversal200_response.rb
|
|
412
|
+
- lib/pharmaobservatory/models/biomarkers_coverage_by_traversal200_response_rows_inner.rb
|
|
413
|
+
- lib/pharmaobservatory/models/biomarkers_evidence_over_time200_response.rb
|
|
414
|
+
- lib/pharmaobservatory/models/biomarkers_evidence_over_time200_response_context.rb
|
|
415
|
+
- lib/pharmaobservatory/models/biomarkers_evidence_over_time200_response_rows_inner.rb
|
|
416
|
+
- lib/pharmaobservatory/models/biomarkers_fda_bqp200_response.rb
|
|
417
|
+
- lib/pharmaobservatory/models/biomarkers_fda_bqp200_response_rows_inner.rb
|
|
418
|
+
- lib/pharmaobservatory/models/biomarkers_fda_cdx200_response.rb
|
|
419
|
+
- lib/pharmaobservatory/models/biomarkers_fda_cdx200_response_rows_inner.rb
|
|
420
|
+
- lib/pharmaobservatory/models/biomarkers_get200_response.rb
|
|
421
|
+
- lib/pharmaobservatory/models/biomarkers_get200_response_identity.rb
|
|
422
|
+
- lib/pharmaobservatory/models/biomarkers_get200_response_identity_rows_inner.rb
|
|
423
|
+
- lib/pharmaobservatory/models/biomarkers_get200_response_identity_rows_inner_value.rb
|
|
424
|
+
- lib/pharmaobservatory/models/biomarkers_get200_response_resolution_confidence.rb
|
|
425
|
+
- lib/pharmaobservatory/models/biomarkers_get200_response_sections_inner.rb
|
|
426
|
+
- lib/pharmaobservatory/models/biomarkers_hub_tier_tables200_response.rb
|
|
427
|
+
- lib/pharmaobservatory/models/biomarkers_hub_tier_tables200_response_rows_inner.rb
|
|
428
|
+
- lib/pharmaobservatory/models/biomarkers_identity200_response.rb
|
|
429
|
+
- lib/pharmaobservatory/models/biomarkers_list200_response.rb
|
|
430
|
+
- lib/pharmaobservatory/models/biomarkers_list200_response_attribution_inner.rb
|
|
431
|
+
- lib/pharmaobservatory/models/biomarkers_list200_response_build_state.rb
|
|
432
|
+
- lib/pharmaobservatory/models/biomarkers_list200_response_columns_inner.rb
|
|
433
|
+
- lib/pharmaobservatory/models/biomarkers_list200_response_facets_inner.rb
|
|
434
|
+
- lib/pharmaobservatory/models/biomarkers_list200_response_facets_inner_options_inner.rb
|
|
435
|
+
- lib/pharmaobservatory/models/biomarkers_list200_response_pagination.rb
|
|
436
|
+
- lib/pharmaobservatory/models/biomarkers_list200_response_query.rb
|
|
437
|
+
- lib/pharmaobservatory/models/biomarkers_list200_response_query_filters.rb
|
|
438
|
+
- lib/pharmaobservatory/models/biomarkers_list200_response_rows_inner.rb
|
|
439
|
+
- lib/pharmaobservatory/models/biomarkers_list200_response_shape.rb
|
|
440
|
+
- lib/pharmaobservatory/models/biomarkers_literature200_response.rb
|
|
441
|
+
- lib/pharmaobservatory/models/biomarkers_literature200_response_context.rb
|
|
442
|
+
- lib/pharmaobservatory/models/biomarkers_literature200_response_rows_inner.rb
|
|
443
|
+
- lib/pharmaobservatory/models/biomarkers_ot_association200_response.rb
|
|
444
|
+
- lib/pharmaobservatory/models/biomarkers_ot_association200_response_rows_inner.rb
|
|
445
|
+
- lib/pharmaobservatory/models/biomarkers_population_allele_frequency200_response.rb
|
|
446
|
+
- lib/pharmaobservatory/models/biomarkers_population_allele_frequency200_response_attribution_inner.rb
|
|
447
|
+
- lib/pharmaobservatory/models/biomarkers_population_allele_frequency200_response_rows_inner.rb
|
|
448
|
+
- lib/pharmaobservatory/models/biomarkers_publishing_org200_response.rb
|
|
449
|
+
- lib/pharmaobservatory/models/biomarkers_publishing_org200_response_context.rb
|
|
450
|
+
- lib/pharmaobservatory/models/biomarkers_publishing_org200_response_rows_inner.rb
|
|
451
|
+
- lib/pharmaobservatory/models/biomarkers_related_biomarkers200_response.rb
|
|
452
|
+
- lib/pharmaobservatory/models/biomarkers_related_biomarkers200_response_rows_inner.rb
|
|
453
|
+
- lib/pharmaobservatory/models/biomarkers_related_conditions200_response.rb
|
|
454
|
+
- lib/pharmaobservatory/models/biomarkers_related_organizations200_response.rb
|
|
455
|
+
- lib/pharmaobservatory/models/biomarkers_relations200_response.rb
|
|
456
|
+
- lib/pharmaobservatory/models/biomarkers_relations200_response_context.rb
|
|
457
|
+
- lib/pharmaobservatory/models/biomarkers_relations200_response_context_filters.rb
|
|
458
|
+
- lib/pharmaobservatory/models/biomarkers_relations200_response_query.rb
|
|
459
|
+
- lib/pharmaobservatory/models/biomarkers_relations200_response_rows_inner.rb
|
|
460
|
+
- lib/pharmaobservatory/models/biomarkers_relations400_response.rb
|
|
461
|
+
- lib/pharmaobservatory/models/biomarkers_sample_screening200_response.rb
|
|
462
|
+
- lib/pharmaobservatory/models/biomarkers_sample_screening200_response_context.rb
|
|
463
|
+
- lib/pharmaobservatory/models/biomarkers_sample_screening200_response_context_coverage_counts.rb
|
|
464
|
+
- lib/pharmaobservatory/models/biomarkers_sample_screening200_response_rows_inner.rb
|
|
465
|
+
- lib/pharmaobservatory/models/biomarkers_sample_screening200_response_rows_inner_reference_screens.rb
|
|
466
|
+
- lib/pharmaobservatory/models/biomarkers_trial_mention200_response.rb
|
|
467
|
+
- lib/pharmaobservatory/models/biomarkers_trial_mention200_response_rows_inner.rb
|
|
468
|
+
- lib/pharmaobservatory/models/biomarkers_variant_mentions200_response.rb
|
|
469
|
+
- lib/pharmaobservatory/models/biomarkers_variant_mentions200_response_rows_inner.rb
|
|
470
|
+
- lib/pharmaobservatory/models/biomarkers_vendor_sourcing200_response.rb
|
|
471
|
+
- lib/pharmaobservatory/models/biomarkers_vendor_sourcing200_response_query.rb
|
|
472
|
+
- lib/pharmaobservatory/models/biomarkers_vendor_sourcing200_response_rows_inner.rb
|
|
473
|
+
- lib/pharmaobservatory/models/biomarkers_where_it_appears200_response.rb
|
|
474
|
+
- lib/pharmaobservatory/models/biomarkers_where_it_appears200_response_rows_inner.rb
|
|
475
|
+
- lib/pharmaobservatory/models/cell_lines_get200_response.rb
|
|
476
|
+
- lib/pharmaobservatory/models/cell_lines_get200_response_identity.rb
|
|
477
|
+
- lib/pharmaobservatory/models/cell_lines_get200_response_identity_rows_inner.rb
|
|
478
|
+
- lib/pharmaobservatory/models/cell_lines_identity200_response.rb
|
|
479
|
+
- lib/pharmaobservatory/models/cell_lines_list200_response.rb
|
|
480
|
+
- lib/pharmaobservatory/models/cell_lines_list200_response_attribution_inner.rb
|
|
481
|
+
- lib/pharmaobservatory/models/cell_lines_list200_response_query.rb
|
|
482
|
+
- lib/pharmaobservatory/models/cell_lines_list200_response_query_filters.rb
|
|
483
|
+
- lib/pharmaobservatory/models/cell_lines_list200_response_rows_inner.rb
|
|
484
|
+
- lib/pharmaobservatory/models/cell_lines_safety_resolution200_response.rb
|
|
485
|
+
- lib/pharmaobservatory/models/cell_lines_safety_resolution200_response_rows_inner.rb
|
|
486
|
+
- lib/pharmaobservatory/models/cell_lines_safety_resolution200_response_rows_inner_value.rb
|
|
487
|
+
- lib/pharmaobservatory/models/cell_lines_status_counts200_response.rb
|
|
488
|
+
- lib/pharmaobservatory/models/cell_lines_status_counts200_response_rows_inner.rb
|
|
433
489
|
- lib/pharmaobservatory/models/not_entitled_error.rb
|
|
490
|
+
- lib/pharmaobservatory/models/orgs_active_programs200_response.rb
|
|
491
|
+
- lib/pharmaobservatory/models/orgs_activity_summary200_response.rb
|
|
492
|
+
- lib/pharmaobservatory/models/orgs_activity_summary200_response_rows_inner.rb
|
|
493
|
+
- lib/pharmaobservatory/models/orgs_approved_assets200_response.rb
|
|
494
|
+
- lib/pharmaobservatory/models/orgs_approved_assets200_response_context.rb
|
|
495
|
+
- lib/pharmaobservatory/models/orgs_approved_assets200_response_rows_inner.rb
|
|
496
|
+
- lib/pharmaobservatory/models/orgs_benzinga_catalysts200_response.rb
|
|
497
|
+
- lib/pharmaobservatory/models/orgs_benzinga_catalysts200_response_attribution_inner.rb
|
|
498
|
+
- lib/pharmaobservatory/models/orgs_benzinga_catalysts200_response_restriction.rb
|
|
499
|
+
- lib/pharmaobservatory/models/orgs_biomarker_capability200_response.rb
|
|
500
|
+
- lib/pharmaobservatory/models/orgs_clia200_response.rb
|
|
501
|
+
- lib/pharmaobservatory/models/orgs_climate200_response.rb
|
|
502
|
+
- lib/pharmaobservatory/models/orgs_climate200_response_rows_inner.rb
|
|
503
|
+
- lib/pharmaobservatory/models/orgs_collaborators200_response.rb
|
|
504
|
+
- lib/pharmaobservatory/models/orgs_collaborators200_response_rows_inner.rb
|
|
505
|
+
- lib/pharmaobservatory/models/orgs_company200_response.rb
|
|
506
|
+
- lib/pharmaobservatory/models/orgs_company200_response_rows_inner.rb
|
|
507
|
+
- lib/pharmaobservatory/models/orgs_competitors200_response.rb
|
|
508
|
+
- lib/pharmaobservatory/models/orgs_competitors200_response_rows_inner.rb
|
|
509
|
+
- lib/pharmaobservatory/models/orgs_coverage200_response.rb
|
|
510
|
+
- lib/pharmaobservatory/models/orgs_coverage200_response_rows_inner.rb
|
|
511
|
+
- lib/pharmaobservatory/models/orgs_coverage200_response_rows_inner_value.rb
|
|
512
|
+
- lib/pharmaobservatory/models/orgs_current_ownership200_response.rb
|
|
513
|
+
- lib/pharmaobservatory/models/orgs_current_ownership200_response_attribution_inner.rb
|
|
514
|
+
- lib/pharmaobservatory/models/orgs_current_ownership200_response_context.rb
|
|
515
|
+
- lib/pharmaobservatory/models/orgs_current_ownership200_response_context_totals.rb
|
|
516
|
+
- lib/pharmaobservatory/models/orgs_current_ownership200_response_rows_inner.rb
|
|
517
|
+
- lib/pharmaobservatory/models/orgs_declarations200_response.rb
|
|
518
|
+
- lib/pharmaobservatory/models/orgs_declarations200_response_rows_inner.rb
|
|
519
|
+
- lib/pharmaobservatory/models/orgs_delivery200_response.rb
|
|
520
|
+
- lib/pharmaobservatory/models/orgs_delivery200_response_rows_inner.rb
|
|
521
|
+
- lib/pharmaobservatory/models/orgs_description200_response.rb
|
|
522
|
+
- lib/pharmaobservatory/models/orgs_description200_response_rows_inner.rb
|
|
523
|
+
- lib/pharmaobservatory/models/orgs_disease_areas200_response.rb
|
|
524
|
+
- lib/pharmaobservatory/models/orgs_disease_areas200_response_rows_inner.rb
|
|
525
|
+
- lib/pharmaobservatory/models/orgs_diversity200_response.rb
|
|
526
|
+
- lib/pharmaobservatory/models/orgs_diversity200_response_rows_inner.rb
|
|
527
|
+
- lib/pharmaobservatory/models/orgs_esg_trend200_response.rb
|
|
528
|
+
- lib/pharmaobservatory/models/orgs_esg_trend200_response_attribution_inner.rb
|
|
529
|
+
- lib/pharmaobservatory/models/orgs_esg_trend200_response_context.rb
|
|
530
|
+
- lib/pharmaobservatory/models/orgs_esg_trend200_response_rows_inner.rb
|
|
531
|
+
- lib/pharmaobservatory/models/orgs_financial_line_items200_response.rb
|
|
532
|
+
- lib/pharmaobservatory/models/orgs_financial_line_items200_response_context.rb
|
|
533
|
+
- lib/pharmaobservatory/models/orgs_financial_line_items200_response_context_groups_inner.rb
|
|
534
|
+
- lib/pharmaobservatory/models/orgs_financial_line_items200_response_rows_inner.rb
|
|
535
|
+
- lib/pharmaobservatory/models/orgs_financial_overview200_response.rb
|
|
536
|
+
- lib/pharmaobservatory/models/orgs_financial_overview200_response_context.rb
|
|
537
|
+
- lib/pharmaobservatory/models/orgs_financial_overview200_response_rows_inner.rb
|
|
538
|
+
- lib/pharmaobservatory/models/orgs_financial_overview200_response_rows_inner_value.rb
|
|
539
|
+
- lib/pharmaobservatory/models/orgs_financials200_response.rb
|
|
540
|
+
- lib/pharmaobservatory/models/orgs_financials200_response_rows_inner.rb
|
|
541
|
+
- lib/pharmaobservatory/models/orgs_funding200_response.rb
|
|
542
|
+
- lib/pharmaobservatory/models/orgs_funding200_response_context.rb
|
|
543
|
+
- lib/pharmaobservatory/models/orgs_funding200_response_context_summary.rb
|
|
544
|
+
- lib/pharmaobservatory/models/orgs_funding200_response_rows_inner.rb
|
|
545
|
+
- lib/pharmaobservatory/models/orgs_get200_response.rb
|
|
546
|
+
- lib/pharmaobservatory/models/orgs_get200_response_identity.rb
|
|
547
|
+
- lib/pharmaobservatory/models/orgs_get200_response_identity_rows_inner.rb
|
|
548
|
+
- lib/pharmaobservatory/models/orgs_get200_response_identity_rows_inner_value.rb
|
|
549
|
+
- lib/pharmaobservatory/models/orgs_get200_response_sections_inner.rb
|
|
550
|
+
- lib/pharmaobservatory/models/orgs_group_sections200_response.rb
|
|
551
|
+
- lib/pharmaobservatory/models/orgs_group_sections200_response_context.rb
|
|
552
|
+
- lib/pharmaobservatory/models/orgs_group_sections200_response_rows_inner.rb
|
|
553
|
+
- lib/pharmaobservatory/models/orgs_group_structure200_response.rb
|
|
554
|
+
- lib/pharmaobservatory/models/orgs_group_structure200_response_context.rb
|
|
555
|
+
- lib/pharmaobservatory/models/orgs_group_structure200_response_rows_inner.rb
|
|
556
|
+
- lib/pharmaobservatory/models/orgs_gxp_sites200_response.rb
|
|
557
|
+
- lib/pharmaobservatory/models/orgs_gxp_sites200_response_context.rb
|
|
558
|
+
- lib/pharmaobservatory/models/orgs_gxp_sites200_response_context_group_companies_inner.rb
|
|
559
|
+
- lib/pharmaobservatory/models/orgs_gxp_sites200_response_rows_inner.rb
|
|
560
|
+
- lib/pharmaobservatory/models/orgs_gxp_sites_map200_response.rb
|
|
561
|
+
- lib/pharmaobservatory/models/orgs_identity200_response.rb
|
|
562
|
+
- lib/pharmaobservatory/models/orgs_import_refusals200_response.rb
|
|
563
|
+
- lib/pharmaobservatory/models/orgs_institutional13f200_response.rb
|
|
564
|
+
- lib/pharmaobservatory/models/orgs_institutional13f200_response_context.rb
|
|
565
|
+
- lib/pharmaobservatory/models/orgs_institutional13f200_response_rows_inner.rb
|
|
566
|
+
- lib/pharmaobservatory/models/orgs_journals200_response.rb
|
|
567
|
+
- lib/pharmaobservatory/models/orgs_list200_response.rb
|
|
568
|
+
- lib/pharmaobservatory/models/orgs_list200_response_pagination.rb
|
|
569
|
+
- lib/pharmaobservatory/models/orgs_list200_response_query.rb
|
|
570
|
+
- lib/pharmaobservatory/models/orgs_list200_response_rows_inner.rb
|
|
571
|
+
- lib/pharmaobservatory/models/orgs_member_children200_response.rb
|
|
572
|
+
- lib/pharmaobservatory/models/orgs_member_identity200_response.rb
|
|
573
|
+
- lib/pharmaobservatory/models/orgs_member_identity200_response_context.rb
|
|
574
|
+
- lib/pharmaobservatory/models/orgs_member_identity200_response_context_identifiers_inner.rb
|
|
575
|
+
- lib/pharmaobservatory/models/orgs_member_identity200_response_context_parent.rb
|
|
576
|
+
- lib/pharmaobservatory/models/orgs_member_identity200_response_rows_inner.rb
|
|
577
|
+
- lib/pharmaobservatory/models/orgs_member_records200_response.rb
|
|
578
|
+
- lib/pharmaobservatory/models/orgs_member_records200_response_context.rb
|
|
579
|
+
- lib/pharmaobservatory/models/orgs_member_records200_response_rows_inner.rb
|
|
580
|
+
- lib/pharmaobservatory/models/orgs_members200_response.rb
|
|
581
|
+
- lib/pharmaobservatory/models/orgs_members200_response_rows_inner.rb
|
|
582
|
+
- lib/pharmaobservatory/models/orgs_org_assets200_response.rb
|
|
583
|
+
- lib/pharmaobservatory/models/orgs_org_assets200_response_rows_inner.rb
|
|
584
|
+
- lib/pharmaobservatory/models/orgs_org_customer200_response.rb
|
|
585
|
+
- lib/pharmaobservatory/models/orgs_org_customer200_response_rows_inner.rb
|
|
586
|
+
- lib/pharmaobservatory/models/orgs_org_gleif200_response.rb
|
|
587
|
+
- lib/pharmaobservatory/models/orgs_org_gleif200_response_rows_inner.rb
|
|
588
|
+
- lib/pharmaobservatory/models/orgs_org_hosted200_response.rb
|
|
589
|
+
- lib/pharmaobservatory/models/orgs_org_hosted200_response_rows_inner.rb
|
|
590
|
+
- lib/pharmaobservatory/models/orgs_org_owned_drugs200_response.rb
|
|
591
|
+
- lib/pharmaobservatory/models/orgs_org_owned_drugs200_response_rows_inner.rb
|
|
592
|
+
- lib/pharmaobservatory/models/orgs_org_ownership200_response.rb
|
|
593
|
+
- lib/pharmaobservatory/models/orgs_org_ownership200_response_context.rb
|
|
594
|
+
- lib/pharmaobservatory/models/orgs_org_ownership200_response_context_truncated.rb
|
|
595
|
+
- lib/pharmaobservatory/models/orgs_org_patent_mentions200_response.rb
|
|
596
|
+
- lib/pharmaobservatory/models/orgs_org_patent_mentions200_response_attribution_inner.rb
|
|
597
|
+
- lib/pharmaobservatory/models/orgs_org_patent_mentions200_response_rows_inner.rb
|
|
598
|
+
- lib/pharmaobservatory/models/orgs_org_people200_response.rb
|
|
599
|
+
- lib/pharmaobservatory/models/orgs_org_people200_response_context.rb
|
|
600
|
+
- lib/pharmaobservatory/models/orgs_org_people200_response_rows_inner.rb
|
|
601
|
+
- lib/pharmaobservatory/models/orgs_org_pipeline200_response.rb
|
|
602
|
+
- lib/pharmaobservatory/models/orgs_org_pipeline200_response_context.rb
|
|
603
|
+
- lib/pharmaobservatory/models/orgs_org_pipeline200_response_context_counts.rb
|
|
604
|
+
- lib/pharmaobservatory/models/orgs_org_pipeline200_response_rows_inner.rb
|
|
605
|
+
- lib/pharmaobservatory/models/orgs_org_programs200_response.rb
|
|
606
|
+
- lib/pharmaobservatory/models/orgs_org_programs200_response_context.rb
|
|
607
|
+
- lib/pharmaobservatory/models/orgs_org_programs200_response_rows_inner.rb
|
|
608
|
+
- lib/pharmaobservatory/models/orgs_org_publications200_response.rb
|
|
609
|
+
- lib/pharmaobservatory/models/orgs_org_publications200_response_rows_inner.rb
|
|
610
|
+
- lib/pharmaobservatory/models/orgs_org_recruitment200_response.rb
|
|
611
|
+
- lib/pharmaobservatory/models/orgs_org_recruitment200_response_context.rb
|
|
612
|
+
- lib/pharmaobservatory/models/orgs_org_recruitment200_response_context_predicted.rb
|
|
613
|
+
- lib/pharmaobservatory/models/orgs_org_recruitment200_response_context_realized.rb
|
|
614
|
+
- lib/pharmaobservatory/models/orgs_org_recruitment200_response_context_statuses.rb
|
|
615
|
+
- lib/pharmaobservatory/models/orgs_org_relationships200_response.rb
|
|
616
|
+
- lib/pharmaobservatory/models/orgs_org_relationships200_response_query.rb
|
|
617
|
+
- lib/pharmaobservatory/models/orgs_org_supplier200_response.rb
|
|
618
|
+
- lib/pharmaobservatory/models/orgs_org_supplier200_response_rows_inner.rb
|
|
619
|
+
- lib/pharmaobservatory/models/orgs_org_targets200_response.rb
|
|
620
|
+
- lib/pharmaobservatory/models/orgs_org_targets200_response_rows_inner.rb
|
|
621
|
+
- lib/pharmaobservatory/models/orgs_org_type_tally200_response.rb
|
|
622
|
+
- lib/pharmaobservatory/models/orgs_org_type_tally200_response_context.rb
|
|
623
|
+
- lib/pharmaobservatory/models/orgs_org_type_tally200_response_rows_inner.rb
|
|
624
|
+
- lib/pharmaobservatory/models/orgs_org_us_patents200_response.rb
|
|
625
|
+
- lib/pharmaobservatory/models/orgs_org_us_patents200_response_context.rb
|
|
626
|
+
- lib/pharmaobservatory/models/orgs_org_us_patents200_response_rows_inner.rb
|
|
627
|
+
- lib/pharmaobservatory/models/orgs_overview_digest200_response.rb
|
|
628
|
+
- lib/pharmaobservatory/models/orgs_overview_digest200_response_rows_inner.rb
|
|
629
|
+
- lib/pharmaobservatory/models/orgs_ownership_coverage200_response.rb
|
|
630
|
+
- lib/pharmaobservatory/models/orgs_ownership_coverage200_response_rows_inner.rb
|
|
631
|
+
- lib/pharmaobservatory/models/orgs_ownership_history200_response.rb
|
|
632
|
+
- lib/pharmaobservatory/models/orgs_ownership_history200_response_context.rb
|
|
633
|
+
- lib/pharmaobservatory/models/orgs_ownership_history200_response_rows_inner.rb
|
|
634
|
+
- lib/pharmaobservatory/models/orgs_ownership_percentages200_response.rb
|
|
635
|
+
- lib/pharmaobservatory/models/orgs_ownership_percentages200_response_context.rb
|
|
636
|
+
- lib/pharmaobservatory/models/orgs_ownership_percentages200_response_context_insider.rb
|
|
637
|
+
- lib/pharmaobservatory/models/orgs_ownership_percentages200_response_context_institutional.rb
|
|
638
|
+
- lib/pharmaobservatory/models/orgs_ownership_percentages200_response_context_shares_outstanding.rb
|
|
639
|
+
- lib/pharmaobservatory/models/orgs_ownership_percentages200_response_rows_inner.rb
|
|
640
|
+
- lib/pharmaobservatory/models/orgs_ownership_percentages200_response_rows_inner_as_of.rb
|
|
641
|
+
- lib/pharmaobservatory/models/orgs_patent_cliff200_response.rb
|
|
642
|
+
- lib/pharmaobservatory/models/orgs_patent_cliff200_response_context.rb
|
|
643
|
+
- lib/pharmaobservatory/models/orgs_patent_cliff200_response_rows_inner.rb
|
|
644
|
+
- lib/pharmaobservatory/models/orgs_patent_vs_trial200_response.rb
|
|
645
|
+
- lib/pharmaobservatory/models/orgs_patent_vs_trial200_response_context.rb
|
|
646
|
+
- lib/pharmaobservatory/models/orgs_patent_vs_trial200_response_context_portfolio.rb
|
|
647
|
+
- lib/pharmaobservatory/models/orgs_patent_vs_trial200_response_rows_inner.rb
|
|
648
|
+
- lib/pharmaobservatory/models/orgs_patents200_response.rb
|
|
649
|
+
- lib/pharmaobservatory/models/orgs_patents200_response_context.rb
|
|
650
|
+
- lib/pharmaobservatory/models/orgs_patents200_response_rows_inner.rb
|
|
651
|
+
- lib/pharmaobservatory/models/orgs_pdufa_reconciliation200_response.rb
|
|
652
|
+
- lib/pharmaobservatory/models/orgs_pdufa_reconciliation200_response_context.rb
|
|
653
|
+
- lib/pharmaobservatory/models/orgs_pdufa_reconciliation200_response_context_status_counts.rb
|
|
654
|
+
- lib/pharmaobservatory/models/orgs_pdufa_reconciliation200_response_rows_inner.rb
|
|
655
|
+
- lib/pharmaobservatory/models/orgs_peers200_response.rb
|
|
656
|
+
- lib/pharmaobservatory/models/orgs_peers200_response_rows_inner.rb
|
|
657
|
+
- lib/pharmaobservatory/models/orgs_phase_status200_response.rb
|
|
658
|
+
- lib/pharmaobservatory/models/orgs_phase_status200_response_context.rb
|
|
659
|
+
- lib/pharmaobservatory/models/orgs_phase_status200_response_rows_inner.rb
|
|
660
|
+
- lib/pharmaobservatory/models/orgs_publishing_biomarkers200_response.rb
|
|
661
|
+
- lib/pharmaobservatory/models/orgs_publishing_biomarkers200_response_context.rb
|
|
662
|
+
- lib/pharmaobservatory/models/orgs_publishing_biomarkers200_response_context_coverage.rb
|
|
663
|
+
- lib/pharmaobservatory/models/orgs_rare_activity200_response.rb
|
|
664
|
+
- lib/pharmaobservatory/models/orgs_rare_activity200_response_context.rb
|
|
665
|
+
- lib/pharmaobservatory/models/orgs_rare_activity200_response_rows_inner.rb
|
|
666
|
+
- lib/pharmaobservatory/models/orgs_registry_shell200_response.rb
|
|
667
|
+
- lib/pharmaobservatory/models/orgs_registry_shell200_response_rows_inner.rb
|
|
668
|
+
- lib/pharmaobservatory/models/orgs_related_conditions200_response.rb
|
|
669
|
+
- lib/pharmaobservatory/models/orgs_related_conditions200_response_rows_inner.rb
|
|
670
|
+
- lib/pharmaobservatory/models/orgs_related_unfolded200_response.rb
|
|
671
|
+
- lib/pharmaobservatory/models/orgs_related_unfolded200_response_rows_inner.rb
|
|
672
|
+
- lib/pharmaobservatory/models/orgs_revenue_by_drug200_response.rb
|
|
673
|
+
- lib/pharmaobservatory/models/orgs_revenue_by_drug200_response_context.rb
|
|
674
|
+
- lib/pharmaobservatory/models/orgs_revenue_by_drug200_response_rows_inner.rb
|
|
675
|
+
- lib/pharmaobservatory/models/orgs_revenue_geography200_response.rb
|
|
676
|
+
- lib/pharmaobservatory/models/orgs_revenue_geography200_response_context.rb
|
|
677
|
+
- lib/pharmaobservatory/models/orgs_revenue_geography200_response_rows_inner.rb
|
|
678
|
+
- lib/pharmaobservatory/models/orgs_same_name_sec_filer200_response.rb
|
|
679
|
+
- lib/pharmaobservatory/models/orgs_same_name_sec_filer200_response_rows_inner.rb
|
|
680
|
+
- lib/pharmaobservatory/models/orgs_sbti_crosscheck200_response.rb
|
|
681
|
+
- lib/pharmaobservatory/models/orgs_sbti_crosscheck200_response_rows_inner.rb
|
|
682
|
+
- lib/pharmaobservatory/models/orgs_scientist_com200_response.rb
|
|
683
|
+
- lib/pharmaobservatory/models/orgs_scientist_com200_response_context.rb
|
|
684
|
+
- lib/pharmaobservatory/models/orgs_scientist_com200_response_rows_inner.rb
|
|
685
|
+
- lib/pharmaobservatory/models/orgs_sec_filer_shell200_response.rb
|
|
686
|
+
- lib/pharmaobservatory/models/orgs_sec_filer_shell200_response_rows_inner.rb
|
|
687
|
+
- lib/pharmaobservatory/models/orgs_sec_filer_shell200_response_rows_inner_value.rb
|
|
688
|
+
- lib/pharmaobservatory/models/orgs_sec_filer_shell200_response_rows_inner_value_one_of.rb
|
|
689
|
+
- lib/pharmaobservatory/models/orgs_sec_pdufa200_response.rb
|
|
690
|
+
- lib/pharmaobservatory/models/orgs_sec_pdufa200_response_rows_inner.rb
|
|
691
|
+
- lib/pharmaobservatory/models/orgs_supplier_links200_response.rb
|
|
692
|
+
- lib/pharmaobservatory/models/orgs_timeline200_response.rb
|
|
693
|
+
- lib/pharmaobservatory/models/orgs_timeline200_response_rows_inner.rb
|
|
694
|
+
- lib/pharmaobservatory/models/orgs_top_conditions200_response.rb
|
|
695
|
+
- lib/pharmaobservatory/models/orgs_top_conditions200_response_rows_inner.rb
|
|
696
|
+
- lib/pharmaobservatory/models/orgs_top_drugs200_response.rb
|
|
697
|
+
- lib/pharmaobservatory/models/orgs_top_drugs200_response_rows_inner.rb
|
|
698
|
+
- lib/pharmaobservatory/models/orgs_trials_per_year200_response.rb
|
|
699
|
+
- lib/pharmaobservatory/models/orgs_unmatched_revenue200_response.rb
|
|
700
|
+
- lib/pharmaobservatory/models/orgs_unmatched_revenue200_response_rows_inner.rb
|
|
701
|
+
- lib/pharmaobservatory/models/orgs_unmatched_revenue200_response_rows_inner_value.rb
|
|
434
702
|
- lib/pharmaobservatory/version.rb
|
|
435
703
|
homepage: https://pharmaobservatory.com
|
|
436
704
|
licenses:
|